cytarabine and Lymphoma

cytarabine has been researched along with Lymphoma in 450 studies

Research

Studies (450)

TimeframeStudies, this research(%)All Research%
pre-1990187 (41.56)18.7374
1990's65 (14.44)18.2507
2000's80 (17.78)29.6817
2010's85 (18.89)24.3611
2020's33 (7.33)2.80

Authors

AuthorsStudies
Chou, TH; Kessel, D; Khilanani, P1
Chiba, A; Ebisawa, K; Honda, A; Kurokawa, M; Masamoto, Y; Okazaki, H1
Buege, MJ; Caron, P; Dao, PH; Dixon, BN; Duggan, TA; Falchi, L; Hamilton, A; Hamlin, P; Jarrett, JC; Kumar, A; Leary, MH; Matasar, MJ; Moskowitz, A; Noy, A; Owens, CN; Pak, TK; Von Keudell, G; Younes, A; Zelenetz, AD1
Ashkenazi, M; Avni, B; Grisariu, S; Lebel, E; Stepensky, P; Vainstein, V; Zimran, E1
Bhojwani, D; Brown, P; Burke, MJ; Chang, BH; Chi, YY; Colace, SI; Florendo, E; Gossai, N; Heimbruch, K; Hermiston, ML; Heym, K; Hutchinson, RJ; Huynh, VT; Kaplan, JA; Malvar, J; Mody, R; O'Brien, TA; Place, AE; Pommert, L; Pulakanti, K; Rao, S; Schafer, ES; Shaw, PH; Sposto, R; Stelloh, C; Wayne, A; Ziegler, DS1
Chen, X; Chu, J; Huang, H; Jiang, Y; Jin, Z; Li, C; Liu, S; Qian, C; Qu, C; Wu, D; Xu, T; Yang, H; Zhang, L; Zhang, X; Zhou, J; Zhu, Q1
Avni, B; Gatt, ME; Goldschmidt, N; Grisaro, S; Gural, A; Lavie, D; Lebel, E; Linetski, E; Lossos, A; Makranz, C; Nachmias, B; Rosenberg, S; Saban, R; Shaulov, A; Siegal, T; Vainstein, V; Zimran, E1
Balzarotti, M; Binder, M; Burger, E; Cabras, G; Cavalli, F; Celico, C; Cozens, K; Cwynarski, K; Deckert, M; Fabbri, A; Falautano, M; Ferranti, A; Ferreri, AJM; Finke, J; Fox, CP; Gørløv, JS; Hemmaway, C; Hertenstein, B; Hess, G; Ielmini, N; Ilariucci, F; Illerhaus, G; Johnson, PW; Keller, U; Krampera, M; Krause, SW; La Rosée, P; Linton, KM; Nonis, A; Orsucci, L; Panse, J; Pennese, E; Pisani, F; Politi, LS; Ponzoni, M; Pukrop, T; Pulczynski, E; Roth, A; Rummel, M; Schmoll, HJ; Schorb, E; Smith, J; Stilgenbauer, S; Thurner, L; Tucci, A; Zanni, M; Zucca, E1
Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L1
Cohen, AL; Colman, H; Gelhard, S; Maxwell, A; Mendez, JS1
Ahmad, I; Bambace, N; Bernard, L; Boisjoly, JA; Bouchard, P; Bourguignon, A; Chagnon, M; Cohen, S; Delisle, JS; Fleury, I; Kiss, T; Lachance, S; Mollica, L; Roy, DC; Roy, J; Sauvageau, G; Veilleux, O; Zehr, J1
Berinstein, N; Crump, M; Drori, AK; Hicks, LK; Kridel, R; Liu, J; Prica, A; Suleman, A1
Huang, Y; Jiang, H; Liang, Y; Qian, W; Xu, X; Yu, T; Yuan, X1
Chang, Y; Fu, X; Li, L; Li, X; Lin, M; Nan, F; Shi, C; Sun, Z; Wang, X; Wu, X; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X; Zhou, Z; Zhu, L1
Borawska, A; Dabrowska-Iwanicka, A; Domanska-Czyz, K; Druzd-Sitek, A; Konecki, R; Kotarska, M; Lapinska, G; Michalski, W; Mroz-Zycinska, E; Osiadacz, W; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Poplawska, L; Romejko-Jarosinska, J; Rymkiewicz, G; Swierkowska, M; Szymanski, M; Tajer, J; Targonski, L; Walewski, J; Wojciechowska-Lampka, E; Wojewodzka-Mirocha, M1
Agrawal, P; Bachanova, V; Berg, S; Bond, DA; Cai, J; Carter, J; Chang, J; Cleveland, J; David, KA; Epperla, N; Evens, AM; Folstad, M; Glantz, M; Goldlust, SA; Graber, J; Habib, A; Hossain, N; Kahl, B; Karmali, R; Kim, MS; Kim, SH; Kumar, P; Lin, Y; Major, A; Malecek, MK; Martin, P; Mier-Hicks, A; Naik, S; Ney, D; Ollila, TA; Rajakumar, P; Reddy, N; Rubenstein, J; Salman, S; Sieg, A; Singer, S; Smith, SM; Spurgeon, S; Strouse, C; Sundaram, S; Torka, P; Tsang, M; Vaca, R; Vendiola, JA; Venugopal, P; Zayac, A1
Akita, T; Asano, K; Fudaba, H; Fujii, K; Hosoya, T; Ideguchi, M; Kakuta, K; Kambe, A; Katayama, K; Kawasaki, Y; Koizumi, S; Kurozumi, K; Nagashima, H; Nakayama, N; Natsumeda, M; Nishibuchi, I; Nishizaki, T; Sasayama, T; Shimabukuro, T; Sugiyama, K; Taguchi, K; Tanaka, K; Tsukamoto, Y; Yamasaki, F; Yasutomo, M; Yonezawa, U; Yoshida, K1
Avni, B; Cohen, YI; Grisariu, S; Lebel, E; Shaulov, A; Stepensky, P; Zimran, E1
Baba, S; Hiu, T; Imaizumi, Y; Izumo, T; Kato, T; Matsuo, A; Matsuo, T; Miyazaki, Y; Morimoto, S; Morofuji, Y; Niino, D; Okano, S; Ujifuku, K; Yamaguchi, S; Yoshida, K; Yoshida, M1
Ahern, K; Correia De Farias, M; Pham, J; Sanderson, R; Walsh, K1
Ashizawa, M; Fujiwara, SI; Genda, H; Hatano, K; Ikeda, T; Ito, S; Kanda, Y; Kawaguchi, SI; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Ochi, SI; Oh, I; Ohmine, K; Sato, K; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R1
Bazarbachi, A; Bou Akl, I; El-Cheikh, J; Ghaoui, N; Karout, L; Khalil, PB; Massoud, R; Matar, M; Zahreddine, A1
Ding, B; Zhang, M; Zhang, YQ; Zhao, SX1
Ballotta, L; Capria, S; Celentano, M; Ferrara, F; Marchesi, F; Mengarelli, A; Papa, E; Pedata, M; Picardi, A; Regazzo, G; Riccardi, C; Riemma, C; Terrenato, I; Trisolini, S1
Beech, A; Bishton, MJ; Fox, CP; Glover, A; Griffiths, C; Martinez-Calle, N; McMillan, A; Richardson, F; Russell, N1
Bode, U; Deckert, M; Egerer, G; Engert, A; Fimmers, R; Fliessbach, K; Herrlinger, U; Klockgether, T; Kowoll, A; Kroschinsky, F; Pels, H; Reichmann, H; Schackert, G; Schlegel, U; Schlömer, S; Schmidt-Wolf, IGH; Seidel, S; Vogt-Schaden, M1
Kelsey, P; Kirkland, K; Lambert, J; Malladi, R; Morley, N; Paul, R; Pearce, R; Peniket, A; Perry, J; Snowden, JA1
Avivi, I; Blumenthal, DT; Bokstein, F; Gibstein, L; Perry, C; Ram, R; Sarid, N; Weiss-Meilik, A1
Blackwood, L; Harper, A; Smallwood, K1
Bakunina, K; Bromberg, JEC; Dirven, L; Doorduijn, JK; Issa, S; van den Bent, MJ; van der Meulen, M1
Akkurt, DM; Cinli, TA; Demir, I; Durusoy, SS; Gunes, AK; Ince, I; Ozkan, G; Pehlivan, M; Sarifakiogullari, S; Serin, I1
Ahamed, SH; Bhattacharyya, R; Chang, KTE; Halepota, HF; Lam, JCM; Le Linn, Y; Lee, YT; Loh, AHP; Othman, MY; Tan, AM1
Aoki, T; Hayakawa, F; Hikita, T; Iwamoto, E; Kagaya, Y; Kiyoi, H; Kunou, S; Oneyama, C; Sakamoto, A; Sanada, M; Shimada, K; Shimada, S; Takai, M1
Birkmann, J; Blaudszun, AR; Bornhäuser, M; Ehninger, G; Fiedler, F; Fricke, S; Hänel, A; Hänel, M; Herbst, R; Kroschinsky, F; Kürzel, S; Schaefer-Eckart, K; Stahl, L1
Chen, PY; Chuang, CC; Hsu, PW; Huang, YC; Jung, SM; Lin, TK; Tu, PH; Wei, KC; Yeh, TH1
Armand, P; Batchelor, TT; Chen, YB; DeFilipp, Z; El-Jawahri, A; Li, S; Nayak, L; Wang, N1
Bai, X; Chen, Y; Ji, N; Liu, F; Liu, J; Liu, Y; Qian, J; Qiu, X; Sun, S; Sun, X; Wang, Y; Zhu, H1
Batlle, M; Feliu, E; Ferra, C; Garcia, O; Ibarra, G; Lopez, D; Moreno, M; Pineda, A; Ribera, JM; Sancho, JM; Sorigue, M; Tapia, G; Vives, S1
Huh, J; Jo, JC; Kang, EH; Kim, JH; Kim, S; Lee, K; Lee, SW; Park, CS; Park, JS; Ryu, JS; Suh, C; Yoon, DH1
Chiba, S; Hasegawa, Y; Hattori, K; Ishikawa, E; Kato, T; Kurita, N; Matsumura, A; Obara, N; Okoshi, Y; Sakata-Yanagimoto, M; Takano, S; Yamamoto, T; Yokoyama, Y1
Elliott, J; Finotello, R1
Birsen, R; Blanc, E; Bouscary, D; Burroni, B; Damotte, D; Deau, B; Dezamis, E; Edjlali, M; Franchi, P; Houillier, C; Kirova, Y; Le Ray, E; Legoff, M; Pallud, J; Pilorge, S; Soussain, C; Tamburini, J; Varlet, P; Vignon, M; Willems, L1
Dünweber, A; Fridthjof, KS; Friis, LS; Gørløv, JS; Kampmann, P; Kjeldsen, L; Moser, C; Møller, T; Nexø, C; Nørskov, KH; Welinder, PC1
Boehm, A; Keil, F; Koller, E; Menschel, E; Moestl, M; Noesslinger, T; Panny, M; Simanek, R1
Billio, A; Borghero, C; Calimeri, T; Carli, G; Cascavilla, N; Centurioni, R; Chiusolo, P; Codeluppi, K; Fama, A; Fanin, R; Federici, I; Ferrero, S; Finotto, S; Gherlinzoni, F; Ghione, P; Giannoccaro, M; Lanza, F; Loseto, G; Marino, D; Matera, R; Mazzone, AM; Mosna, F; Olivieri, A; Olivieri, J; Orciuolo, E; Pelosini, M; Perali, G; Rattotti, S; Saraceni, F; Sgherza, N; Sica, S; Stefani, PM; Tisi, MC; Tomei, G; Zaja, F1
Chang, Y; Duan, L; Fu, X; Li, L; Li, X; Li, Z; Nan, F; Sun, Z; Tian, L; Wang, X; Wu, J; Yan, J; Yu, H; Zhang, L; Zhang, M; Zhang, X1
Ali, H; Budde, E; Chen, R; Forman, SJ; Herrera, AF; Mei, M; Mokhtari, S; Nademanee, A; Nakamura, R; Popplewell, L; Salhotra, A; Sandhu, K; Stiller, T; Zain, J1
Chen, J; Huang, H; Jiang, Y; Jin, Z; Liu, S; Ruan, J; Wu, D; Xiao, X; Zhang, L; Zhang, X1
Brendle, C; la Fougère, C; Nikolaou, K; Pfannenberg, C; Ripkens, S; Soekler, M; Stef, I; Stefan, N1
Bradbury, PA; Chan, KK; Chen, BE; Cheung, M; Cheung, WY; Ding, K; Hay, AE; Kornelsen, EA; Leighl, NB; Mittmann, N; Ng, RCH; Pater, JL; Tu, D1
Alexis, M; Amorim, S; Bay, JO; Chauchet, A; Chrétien, ML; Cluzeau, T; Contentin, N; Cornillon, J; Daguenet, E; de Latour, RP; Dorvaux, V; Gyan, E; Himberlin, C; Huynh, A; Lejeune, C; Mercier, M; Nicolas-Virelizier, E; Salles, G; Vallet, N1
Belada, D; Malý, J; Motyčková, M; Smolej, L; Zák, P1
Dys, P; Jurek, T; Rorat, M; Swiatek, B1
Altuntaş, F; Bozdağ, SC; Demiriz, IŞ; Durgun, G; Koçubaba, S; Sarıca, A; Tekgündüz, E1
Calandrelli, M; Capelli, D; Chiarucci, M; Gini, G; Inglese, E; Leoni, P; Mancini, G; Mancini, S; Montanari, M; Offidani, M; Olivieri, A; Poloni, A; Raggetti, G; Scortechini, I1
Abrey, LE; Correa, DD; Curry, R; DeAngelis, LM; Grant, B; Grimm, S; Karimi, S; Lai, RK; Morris, PG; Omuro, A; Panageas, K; Raizer, JJ; Reiner, AS; Schiff, D; Shah, G; Yahalom, J1
Asou, H; Kiyosawa, K; Maeda, K; Takeuchi, K; Taniai, H1
Monteith, G; Parsons-Doherty, M; Poirier, VJ1
Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Jiang, WQ; Wang, XX; Xia, YF; Xia, ZJ1
Akutsu, M; Furukawa, Y; Hiraoka, N; Kano, Y; Kikuchi, J; Koyama, D; Mori, S; Nakamura, Y; Ueda, T; Uesawa, M; Wada, T; Yamauchi, T1
Cen, J; Li, C; Liu, X; Ma, Y; Mei, K; Qian, L; Shen, J; Wang, Y; Zhao, D1
Baldini, L; Balzarotti, M; Bobbio, F; Brandes, AA; Ciceri, F; Corazzelli, G; Ferreri, AJ; Ilariucci, F; Montanari, M; Reni, M; Spina, M; Stelitano, C; Zaja, F1
Chataway, J; Cockerell, OC; Davagnanam, I; Patani, R; Ramsay, A; Samani, A1
Atalla, A; Costa, LJ; dos Santos, KB; Hallack-Neto, AE; Pereira, J1
D'Sa, S; Dorman, J; Marzolini, MA; Thomson, KJ1
Engert, A; Kasenda, B; Skoetz, N; Zacher, J1
Chang, Y; Fu, XR; Han, LJ; Li, L; Li, X; Ma, W; Sun, ZC; Wang, XH; Wu, JJ; Zhang, L; Zhang, MZ; Zhang, XD1
Kato, S; Konuma, T; Oiwa-Monna, M; Takahashi, S; Tojo, A1
Baetz, T; Buckstein, R; Chen, BE; Couban, S; Crump, M; Di Renzo, N; Djurfeldt, MS; Federico, M; Hay, AE; Howson-Jan, K; Imrie, KR; Kaizer, L; Kouroukis, CT; Kukreti, V; Kuruvilla, J; MacDonald, DA; Meyer, RM; Olney, HJ; Rubinger, M; Shepherd, LE; Sussman, J; Turner, AR; Voralia, M1
Barriere, J; Borchiellini, D; Boscagli, A; Coso, D; Garnier, G; Gastaud, L; Gutnecht, J; Martin, N; Naman, H; Petit, E; Peyrade, F; Re, D; Rossignol, B; Saudes, L; Thyss, A1
Eray, M; Haapasaari, KM; Haapasalo, H; Harjama, L; Jantunen, E; Karjalainen-Lindsberg, ML; Kuittinen, O; Kuitunen, H; Lehtinen, T; Leppä, S; Mannisto, S; Nousiainen, T; Soini, Y; Turpeenniemi-Hujanen, T; Vasala, K; Vornanen, M1
Baetz, T; Chen, BE; Cheung, MC; Couban, S; Crump, M; Desjardins, P; Hassan, S; Hay, AE; Imrie, KR; Kouroukis, CT; Kukreti, V; Le, A; MacDonald, D; Meyer, RM; Mittmann, N; Risebrough, N; Shepherd, L; Song, Y; Sussman, J; Szwajcer, D1
Ahmadzadeh, A; Hajizamani, S; Jalaeikhoo, H; Keyhani, M; Rahim, F; Sadeghi Hariri, B; Saki, N; Yekaninejad, MS1
Gillem, J; Giuffrida, M; Krick, E1
Amorim, S; Bouabdallah, R; Boumendil, A; Choquet, S; de Rosa, G; Delmer, A; Dreger, P; Faber, E; Facchini, L; Falzetti, F; Ferrara, F; Finel, H; Finke, J; Kobbe, G; Nicolas-Virelizier, E; Salles, G; Sayer, H; Scime, R; Sellner, L; Sureda, A; Vallisa, D; Yakoub-Agha, I; Zuffa, E1
Czerw, T; Drozd-Sokolowska, J; Giebel, S; Halaburda, K; Holowiecki, J; Mendrek, W; Najda, J; Nowicki, M; Sadus-Wojciechowska, M; Sobczyk-Kruszelnicka, M; Wierzbowska, A1
Barrié, M; Benouaich-Amiel, A; Chinot, O; Choquet, S; del Rio, MS; Delgadillo, D; Delwail, V; Ghesquieres, H; Gonzalez-Aguilar, A; Gressin, R; Gyan, E; Hoang-Xuan, K; Houillier, C; Huchet, A; Lacomblez, L; Lamy, T; Lebouvier-Sadot, S; Omuro, A; Soubeyran, P; Soussain, C; Taillandier, L; Tanguy, ML; Touitou, V1
Li, M; Liu, L; Wang, Y; Xi, N; Xiao, X1
Agresta, F; Ayton, R; Bennett, A; Bhattacharyya, P; Cooke, RE; Grigg, A; Lasica, M; Stern, C; Taylor, E1
Bag, HG; Berber, I; Erkurt, MA; Kaya, E; Koroglu, M; Kuku, I; Nizam, I; Ozgul, M1
Ai, W; Bence-Bruckler, I; Bierman, P; Braunschweig, I; Chen, AI; Comeau, T; Costa, LJ; Craig, M; Fay, JW; Flinn, I; Flowers, CR; Freytes, CO; Horwitz, ME; Kato, K; Laneuville, P; Le-Rademacher, J; Lill, M; Mason, J; Mineishi, S; Pasquini, MC; Pulsipher, MA; Rodriguez, TE; Rondelli, D; Shea, TC; Shore, TB; Smith, AJ; Vaughan, W; Waller, EK; Wang, Y; Xu, C; Yeager, AM; Yeh, RF1
Hotta, T; Kubo, K; Miyazaki, Y; Murayama, T; Shimazaki, R; Tamura, K; Urabe, A; Usui, N1
Bodaghi, B; Cassoux, N; Choquet, S; Costopoulos, M; Hoang-Xuan, K; Houillier, C; Le Cossec, C; Legarf-Tavernier, M; LeHoang, P; Nguyen, DT; Omuro, A; Soussain, C; Touitou, V1
Ardeshna, KM; Foley, M; Kothari, J; Lambert, J; Linch, DC; Mackenzie, S; Morris, E; Peggs, KS; Thomson, K; Virchis, AE1
Ashizawa, M; Fujiwara, S; Hatano, K; Ito, S; Kako, S; Kanda, Y; Kawasaki, Y; Mashima, K; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R1
Abboud, C; Cashen, AF; Ceriotti, C; DiPersio, J; Fletcher, T; Gao, F; Ghobadi, A; Stockerl-Goldstein, K; Vij, R1
Baran, A; Barr, PM; Becker, MW; Friedberg, JW; Liesveld, JL; Milner, LA; Phillips, GL; Reid, RM; Wedow, L1
Benger, A; Berinstein, NL; Chen, BE; Couban, S; Crump, M; Davison, K; Desjardins, P; Djurfeldt, MS; Hay, AE; Kaizer, L; Kukreti, V; Mangel, J; Shepherd, LE; Zhu, L1
Bachanova, V; Brunstein, CG; Fair, C; Lazaryan, A; McClune, B; Rogosheske, J; Shanley, R1
Fujiwara, SI; Hatano, K; Kanda, Y; Kawasaki, Y; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R1
Bajwa, RPS; Gerhardt, CA; Hagedoorn, M; Keim, MC; Lehmann, V; Olshefski, RS; Tuinman, MA; Winning, AM1
Casper, J; Freund, M; Hilgendorf, I; Junghanss, C; Kahl, C; Leithaeuser, M; Steiner, B; Wolff, D1
Cook, G; Crawley, C; Fields, P; Hickling, R; Hunter, A; Mahendra, P; Marcus, R; Peniket, A; Wilson, K1
Galmarini, CM; Myhren, F; Sandvold, ML1
Bonfanti, U; Comazzi, S; Lorenzo, MR; Marconato, L; Romanelli, G; Stefanello, D; Zini, E1
Agarwal, RP; Fritzer-Szekeres, M; Graser, G; Grusch, M; Hidvegi, M; Jaeger, W; Krupitza, G; Lackner, A; Madlener, S; Ozsvar-Kozma, M; Saiko, P; Szekeres, T1
Alvarez-Larran, A; Barca, EG; Deben, G; Garcia Vela, JA; Garcia, ES; Garcia-Cerecedo, T; Garcia-Marco, JA; Panizo, C; Penarrubia, MJ; Sancho, JM1
Cioch, M; Dudzinski, M; Giebel, S; Hałasz, M; Holowiecka-Goral, A; Hołowiecki, J; Kos, K; Krawczyk-Kulis, M; Lehmann-Kopydłowska, A; Piszcz, J; Preisner, W; Stella-Holowiecka, B1
Hofheinz, RD; Kripp, M1
Swinnen, LJ1
O'Brien, PC; Seymour, JF1
Cascavilla, N; Crescimanno, A; Di Bartolomeo, P; Di Renzo, N; Lanza, F; Marcacci, G; Musso, M; Perrone, T; Pinto, A; Scalone, R1
Biron, P; Blay, JY; Bosly, A; Casasnovas, O; Coiffier, B; Colin, P; Ferlay, C; Ghesquières, H; Haioun, C; Morel, P; Perol, D; Reman, O; Sebban, C; Tilly, H; Van den Neste, E1
Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C1
Jia, YQ; Meng, WT; Ni, X; Wen, Q; Zeng, Y1
Cavalli, F; Cerny, T; Ferreri, AJ; Huitema, AD; Joerger, M; Krähenbühl, S; Reni, M; Schellens, JH; Zucca, E1
Avilés, A; de Jesús Nambo, M; Huerta-Guzmán, J; Neri, N1
Albo, C; Andrade, MA; Casado, P; Diaz, R; Esteban, P; Oujo, E; Torreira, C1
Carrabba, MG; Chiara, A; Ciceri, F; Ferreri, AJ; Foppoli, M; Franzin, A; Politi, LS; Reni, M; Villa, E1
Kowoll, A; Kuhnhenn, J; Ostermann, K; Pels, H; Schlegel, U1
Chiba, S; Hasegawa, Y; Matsumura, A; Okoshi, Y; Sakamoto, N; Takano, S; Taoka, K1
Cabanillas, F2
Bamberg, M; Birnbaum, T; Fischer, L; Griesinger, F; Herrlinger, U; Hertenstein, B; Hundsberger, T; Jahnke, K; Kanz, L; Korfel, A; Leithäuser, M; Martus, P; Mergenthaler, HG; Nägele, T; Pietsch, T; Plasswilm, L; Rauch, M; Röth, A; Thiel, E; von Toll, T; Weller, M1
Abboud, CN; Becker, MW; Bernstein, SH; Constine, LS; Friedberg, JW; Ifthikharuddin, JJ; Liesveld, JL; Loughner, JE; Milner, LA; Phillips, GL; Vesole, DH1
Durrbach, A; Fermé, C; Hanna, C; Matta, C; Moise, L; Pilorge, S; Ribrag, V1
Brion, A; Chauchet, A; Daguindau, E; Deconinck, E; Delaby, P; Fontan, J; Garnache-Ottou, F; Heczko, M; Helias, P; Larosa, F; Legrand, F; Schillinger, F; Vuillier, J1
Corazzelli, G; Fava, S; Ferreri, AJ; Foppoli, M; Franzin, A; Licata, G; Paolini, R; Politi, LS; Ponzoni, M; Reni, M; Stelitano, C; Zaja, F; Zucca, E1
Dreyling, M1
Ashizawa, M; Kako, S; Kanda, Y; Kikuchi, M; Kimura, S; Nakasone, H; Nishida, J; Okuda, S; Oshima, K; Sakamoto, K; Sato, M; Terasako, K; Wada, H; Yamazaki, R1
Choquet, S; del Rio, MS; Fourme, E; Glaisner, S; Hoang-Xuan, K; Janvier, M; Soussain, C1
Hori, M; Nishida, H; Obara, K1
Chen, ZT; Kong, PY; Li, DZ; Li, GH; Sun, JG; Wang, XX; Zhou, YB1
Behler, CM; Cha, S; Damon, LE; Hwang, J; Issa, S; McDermott, M; O'Brien, J; Rubenstein, JL; Shuman, MA; Treseler, P; Valles, F; Wieduwilt, MJ1
André, N; Ciccolini, J; Evrard, A; Iliadis, A; Lacarelle, B; M'Batchi, L; Mercier, C; Ouafik, L; Pourroy, B; Verschuur, A1
Falchi, L; Ferranti, L; Gunnellini, M; Liberati, AM1
Albiero, E; Bernardi, M; Castegnaro, S; Chieregato, K; Madeo, D; Rodeghiero, F; Visco, C; Zanon, C1
Bucher, C; Buser, A; Gerull, S; Halter, J; Heim, D; O'Meara, A; Passweg, J; Stern, M1
Cladera, A; Guinea, JM; Llorente, A; Mateos, C; Panizo, C; Salar, A; Sanchez-Gonzalez, B; Sancho, JM1
Chmielowska, E; Chwieduk, A; Czerw, T; Giebel, S; Glowala-Kosinka, M; Grosicki, S; Holowiecki, J; Jurczyszyn, A; Kruzel, T; Mitrus, I; Najda, J; Nowara, E; Pasiarski, M; Sadus-Wojciechowska, M; Smagur, A1
Levasseur, SD; White, VA; Wittenberg, LA1
Han, X; He, X; Liu, P; Shi, Y; Yang, J1
Hoffmann-Jagielska, M; Jagielski, D; Lechowski, R; Winnicka, A1
Bondesan, P; Caracciolo, D; Cuttica, A; Di Nicola, M; Gallamini, A; Gianni, AM; Magni, M; Matteucci, P; Omedè, P; Pileri, A; Tarella, C; Zallio, F1
DeAngelis, LM; Fisher, B; Schold, SC; Schultz, CJ; Seiferheld, W1
Kagami, Y; Miura, K; Morishima, Y; Ogura, M; Suzuki, R; Taji, H; Takeuchi, T1
Baron, B; Bogdhan, U; Chinot, O; De Beule, N; Delattre, JY; Frenay, M; Hildebrand, J; Hoang-Xuan, K; Soubeyran, P; Taillandier, L1
Cox, J; Johnson, L; Lickliter, JD; McHugh, G; Tan, J; Wickham, NW; Wood, F; Wood, NJ1
Cabanillas, F; Cox, JD; Dabaja, BS; Ha, CS; Kyritsis, AP; Levin, V; McLaughlin, P; Meyers, CA; Preti, HA; Pro, B; Seabrooke, LF; Wilder, RB; Yung, WK1
BOSTWICK, L; EVANS, JS; MENGEL, GD; MUSSER, EA1
Au, WY; Chan, EC; Kwong, YL; Leung, AY; Liang, R; Lie, AK; Ooi, GC; Siu, LL1
Atasoy, A; Bode, U; Deckert, M; Diehl, V; Egerer, G; Engert, A; Fimmers, R; Glasmacher, A; Helmstaedter, C; Klockgether, T; Kroschinsky, F; Pels, H; Reichmann, H; Schackert, G; Schaller, C; Schlegel, U; Schmidt-Wolf, IG; Schulz, H; Vogt-Schaden, M; Zellner, A1
Fehlings, T; Grehl, S; Kleuker, S; Pöttgen, C; Rauhut, F; Schmitz, A; Schwechheimer, K; Stüben, G; Stuschke, M; Wacker, HH; Wilhelm, H1
Bolam, S; Child, JA; Davies, JM; Gilson, D; Howard, MR; Jalihal, SS; Mackie, MJ; McVerry, BA; Moreton, P; Morgan, GJ; Parapia, LA; Smith, GM; Williams, AT1
Bird, KE; Cebra, CK; McDonough, SP; Saulez, MN; Schlipf, JW1
Berthou, C; Colombat, P; Deconinck, E; Delwail, V; Foussard, C; Gaillard, F; Gressin, R; Harousseau, JL; Lucas, V; Milpied, N1
Skandalis, A; Zomas, A1
Ball, ED; Bashey, A; Carrier, E; Chen, YA; Corringham, S; Holman, P; Wang, EH1
Caballero, MD; Cañizo, MC; López-Holgado, N; Martín, A; Mateos, MV; Miguel, JF; Pérez-Simón, JA1
Alpdogan, O; Banerjee, D; Bertino, JR; Budak-Alpdogan, T; Moore, MA; Wang, E1
Anghilieri, M; Cairoli, R; Marbello, L; Minola, E; Morra, E; Nosari, A; Ricci, F1
Assari, S; Bennaceur, AL; Boccaccio, C; Bonnet, ML; Bourhis, JH; Decaudin, D; Farace, F; Greissenger, N; Guillier, M; Marracho, MC; Michon, J; Némati, F; Turhan, AG; Vantelon, JM1
Ikarashi, Y; Imai, C; Kakihara, T; Tanaka, A; Uchiyama, M; Watanabe, A1
Chang, WR; Fu, ZZ; Jin, ZM; Miao, M; Qiu, HY; Shen, YM; Sun, AN; Tang, XW; Wu, DP1
Bauer, W; Fritzer-Szekeres, M; Grusch, M; Hoechtl, T; Horvath, Z; Illmer, C; Krupitza, G; Mader, RM; Madlener, S; Saiko, P; Schott, H; Szekeres, T1
Aydin, F; Bektas, O; Kavgaci, H; Ozdemir, F; Yavuz, AA; Yavuz, MN; Yilmaz, M1
Caballero, MD; del Cañizo, MC; López-Holgado, N; Martín, A; Pérez-Simón, JA; San Miguel, JF; Vázquez, L1
Abboud, CN; Bernstein, SH; Chapman, M; Friedberg, JW; Ifthikharuddin, JJ; Johnson, V; Lancet, JE; Liesveld, JL; Phillips, GL; Spreng, E; Vesole, DH1
Agarwal, RP; Bauer, W; Erlach, N; Fritzer-Szekeres, M; Grusch, M; Hoechtl, T; Horvath, Z; Illmer, C; Jaeger, W; Krupitza, G; Mader, RM; Madlener, S; Saiko, P; Schott, H; Szekeres, T1
Pavlidis, N; Pentheroudakis, G1
Fu, L; Kogoshi, H; Koyama, T; Nara, N; Tohda, S1
Brevet, M; Damaj, G; Garidi, R; Gruson, B; Royer, B; Vaida, I1
Giles, FJ; Huang, P; Keating, MJ; Pelicano, H; Xu, RH; Zhang, H1
Horiike, S; Kanbayashi, Y; Matsumoto, Y; Mukoyama, N; Nishida, K; Nomura, K; Shimizu, D; Taniwaki, M1
Derigs, G; Feuerhake, F; Finke, J; Frickhofen, N; Guttenberger, R; Ihorst, G; Illerhaus, G; Marks, R; Ostertag, C; Volk, B1
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kobayashi, H; Mano, H; Tsunoda, S1
Ishigatsubo, Y; Kanamori, H; Kodama, F; Motomura, S; Tomita, N1
Blechschmidt, M; Bornhäuser, M; Ehninger, G; Hänel, M; Hölig, K; Kroschinsky, F; Oelschlaegel, U; Ordemann, R; Platzbecker, U; Poppe-Thiede, K; Schaich, M1
Braeckman, R; Chamberlain, M; Maria, B; Phuphanich, S1
Bay, JO; Berthou, C; Bertrand, P; Brion, A; Camilleri-Broët, S; Colombat, P; Delepine, R; Delwail, V; Desablens, B; Lamy, T; Lemevel, A; Linassier, C; Rachieru, P1
Arellano, M; Flowers, C; Heffner, LT; Hutcherson, D; Jo Lechowicz, M; Langston, A; Lonial, S; Waller, EK; Winton, E1
Coutinho, F; Dantas, AA; Del Giglio, A; Manhani, AR1
Ebeling, P; Metz, K; Moritz, T; Müller, S; Nowrousian, MR; Passon, J; Schütt, P; Seeber, S; Welt, A1
Arber, C; Bucher, C; Buser, AS; Ghielmini, M; Gratwohl, A; Halter, J; Heim, D; Lohri, A; Meyer-Monard, S; Passweg, JR; Stern, M; Stussi, G; Tichelli, A1
Assouad, S; Belhocine, R; Bourhis, JH; Brault, P; Chaoui, D; de Latour, RP; Decaudin, D; Heshmati, F; Legrand, O; Park, S; Rio, B1
Ishizawa, K1
Ference, SJ; Galor, A; Lee, MS; Peereboom, DM; Perez, VL; Singh, AD; Stevens, GH1
Becker, A; Bode, U; Jaehde, U; Linnebank, M; Pels, H; Schlegel, U; Vezmar, S1
Imataki, O; Kawakami, K; Tamai, Y1
Abrey, LE; Correa, DD; DeAngelis, LM; Grant, B; Lai, RK; LaRocca, R; Raizer, JJ; Schiff, D; Shah, GD; Yahalom, J1
Goldstein, DA; Tessler, HH1
Benesch, M; Urban, C1
Adams, DJ; Giles, F; Jacobsen, TF; Myhren, F; Rizzieri, DA; Sandvold, ML1
Burchenal, JH; Dollinger, MR; Fox, JJ; Kreis, W1
Loo, RV; O'Bryan, RM; Talley, RW; Tucker, WG1
Akahoshi, Y; Kasai, C; Nishimoto, Y; Takeuchi, S1
Anger, G; Fink, R; Höche, D1
Kurowska, M; Rupniewska, ZM1
Haren, JM; Kaneko, Y; Larson, RA; Rowley, JD; Variakojis, D1
Bodey, GP; Burgess, MA; Cabanillas, F; Freireich, EJ1
Archimbaud, E; Blanc, M; Bryon, PA; Coiffier, B; Felman, P; Ffrench, M; Fière, D; Guyotat, D; Rebattu, P; Vuvan, H1
Hirai, H; Kusumoto, K; Miura, Y; Motoyoshi, K; Mutoh, Y; Ohda, M; Ozawa, K; Sakamoto, S; Suda, K; Takagi, S1
David, R; Douay, L; Gorin, NC; Lecomte, D; Lopez, M; Najman, A; Oppenheimer, M; Parlier, Y; Salmon, C; Stachowiak, J2
Stephens, CL1
Yamada, K1
Biron, P; Dutou, L; Ehrsam, A; Hervé, P; Le Mevel, A; Philip, I; Philip, T; Philippe, N; Plouvier, E; Souillet, G1
Barlogie, B; Cabanillas, F; Kantarjian, H; McLaughlin, P; Plunkett, W; Riggs, S; Velasquez, W1
Amadori, S; Avvisati, G; Mandelli, F; Martelli, M; Meloni, G; Monarca, B; Motta, M; Papa, G; Petti, MC; Salvagnini, M1
Beaujean, F; Hartmann, O; Kalifa, C; Lemerle, J; Parmentier, C; Patte, C; Pein, F1
Amadori, S; Avvisati, G; Fenu, S; Mandelli, F; Monarca, B; Papa, G; Petti, MC; Pulsoni, A1
Postma, DS; Wallenborn, PA1
Canellos, GP; Shipp, MA; Takvorian, RC1
Bonmassar, E; Frati, L; Migliorati, G; Pastore, S; Riccardi, C1
Koziner, B; Labriola, D; Lee, BJ; Little, C; Nisce, LZ; Oettgen, H; Sklaroff, R; Straus, DJ; Thaler, HT; Young, CW1
Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Ciepielewska, D; Kaczmarek-Kanold, M; Kościelniak, E; Ochocka, M; Radwańska, U; Sońta-Jakimczyk, D; Sroczyńska, M1
Aherne, GW; Harvey, VJ; Johnston, A; Lister, TA; Piall, EM; Slevin, ML1
Kubota, Y; Masaoka, T; Nakamura, H; Oguma, S; Shibata, H; Takubo, T; Tani, Y; Ueda, T1
Feinstein, DI; Forman, SJ; Koehler, SC; Levine, AM; Liebman, H; Lukes, RJ; Meyer, PR; Paganini-Hill, A; Pockros, A1
Griffin, TW; Rybak, ME; Shah, SS1
Howell, SB; Pfeifle, CE1
Alic, L; Haid, M1
Galletti, F; Sturniolo, MG1
Kim, TH; Ramsay, NK; Sklar, CA1
Oguro, M; Takagi, T1
Galbo, C; Lokich, J1
Aherne, GW; Johnston, A; Lister, TA; Piall, EM; Slevin, ML1
Beardsley, P; Egan, E; Fram, R; Kufe, D; Major, P; Rosenthal, D1
Harada, T; Morikawa, K1
Kuhlmann, J; Rietbrock, N; Wilke, J1
Becker, H; Jürgenssen, OA; Krepler, P; Kundi, M; Mutz, I; Pichler, E; Radaszkiewicz, T; Reinartz, G; Schmidmeier, W; Urban, C1
Castleberry, RP; Crist, WM; Gaddy, D; Holbrook, T; Malluh, A1
Early, AP; Preisler, HD; Rustum, YM; Slocum, H1
Chen, T; Doering, EJ; Falletta, JM; Moore, T; Pullen, J; Ramirez, I; Sullivan, MP; Trueworthy, R1
Barzi, A; Bonmassar, E; Frati, L; Migliorati, G1
Horikoshi, N; Ogawa, M1
David, R; Duhamel, G; Gorin, NC; Najman, A; Parlier, Y; Petit, JC; Salmon, C; Stachowiak, J1
Maruyama, Y; Young, JA1
Richardson, VJ; Ryman, BE1
Curt, GA; Richardson, VJ; Ryman, BE1
Delfini, C; Izzi, T; Lucarelli, G; Porcellini, A1
Abe, I; Hori, K; Saito, S; Sato, H; Suzuki, M1
Khoo, RK; Ng, PR; Todd, D1
Allen, TM; Gyorffy, E; Mausolf, S; McAllister, L1
O'Neill, GJ; Stebbing, N1
Bremer, AM; Hayakawa, T; Mogami, H; Ushio, Y; West, CR; Yamada, K1
Akerman, M; Biörklund, A; Håkansson, L; Stenstam, B; Tropé, C1
Hitzig, WH; Plüss, HJ; Sigg, C1
O'Neill, GJ1
Csoka, K; Larsson, R; Liliemark, J; Nygren, P1
Chang, J; Crowther, D; Morgenstern, GR; Pettengell, R; Radford, JA; Rowlands, M; Scarffe, JH; Testa, NG; Woll, PJ; Young, R1
Fuchsberger, P; Lakota, J1
Amemiya, Y; Miura, Y; Muroi, K; Suzuki, T; Tomizuka, H1
Ben-Shahar, M; Epelbaum, R; Haim, N1
Tobinai, K1
Allen, PD; Castenskiold, EC; Coldwell, RD; Collins, PW; Goldstone, AH; Kelsey, SM; Makin, HL; Newland, AC; Side, LE1
Cantori, I; Ciniero, L; Leoni, P; Mancini, S; Masia, MC; Offidani, M; Olivieri, A; Ombrosi, L; Scalari, P1
Xu, T1
Fujii, H; Kuzuyama, Y; Maekawa, T; Nakagawa, H; Sonoda, Y1
Furuta, H; Miyabe, K; Miyaguchi, M; Sakai, S; Takeda, J; Uozumi, N1
Dreger, P; Eckstein, V; Haferlach, T; Jacobs, S; Löffler, H; Marquardt, P; Müller-Ruchholtz, W; Mülverstedt, T; Schmitz, N; Suttorp, M1
Amador Del Valle, G; Daeschler, T; Felice, MP; Harousseau, JL; Milpied, N; Moreau, P; Richard, P; Richet, H1
Daly, MB; Giguere, JK; Harden, EA; Harman, GH; Johnson, DB; Johnson, RA; Leff, RS; Mercier, RJ; Messerschmidt, GL; Snyder, MJ1
Cabanillas, F; Hagemeister, FB; Hill, D; McLaughlin, P; Moore, DF; Rodriguez, MA; Romaguera, JE; Sarris, AH; Swan, F; Younes, A1
Hashimoto, S; Hasuike, T; Hirai, M; Hirai, N; Kou, KR; Ohta, K; Ohta, T; Takekawa, K; Tanaka, K; Yamane, T1
Baybordi, E; Ghavamzadeh, A; Jahani, M1
Barbot, C; Jazwiec, B; Mahon, FX; Reiffers, J; Rice, A; Vanès, I1
Chatterjee, R; Goldstone, AH; Katz, M; McGarrigle, HH; Mills, W1
Cabanillas, F; Rodriguez, MA1
Cabanillas, F; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, J; Rubenstein, E; Swan, F; Tucker, S; Velasquez, WS1
Breneman, JC; Cherlow, JM; Gaynon, PS; Grossman, NJ; Hammond, GD; Johnstone, HS; Kersey, JH; Sather, HN; Steinherz, PG; Trigg, ME1
Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K1
Johnson, PW; Lister, TA; McCallum, P; Norton, AJ; Rohatiner, AZ; Sweetenham, JW1
Carlson, K; Hagberg, H; Oberg, G; Simonsson, B; Smedmyr, B1
Smith, RJ; Sweetenham, JW1
Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W1
Goldstone, AH; Linch, DC; Mills, W; Strang, J1
DeAngelis, LM; Delattre, JY; Freilich, RJ; Monjour, A1
Dräger, AM; Huijgens, PC; Schuurhuis, GJ; Teule, GJ; van Leeuwen-Stok, AE; Visser-Platier, AW1
de Kreuk, AM; Dräger, AM; Huijgens, PC; Jonkhoff, AR; Legdeur, MC; Oberink, JW; Ossenkoppele, GJ; Schuurhuis, GJ; Westra, G; Zweegman, S1
Fielding, AK; Goldstone, AH; Jamieson, E; Linch, DC; Sullivan, AM; Watts, MJ1
Wiley, JS1
Berdel, WE; Hoppe, B; Knauf, WU; Koenigsmann, MP; Notter, M; Oberberg, D; Reufi, B; Thiel, E1
Abrey, LE; DeAngelis, LM; Yahalom, J1
Clemens, M; Dichgans, J; Herrlinger, U; Kortmann, RD; Meyermann, R; Petersen, D; Schabet, M; Will, BE1
Constine, LS; Hicks, DG; O'Keefe, R; Packman, CH; Rapoport, AP; Rosier, RN; Rowe, JM; Rubin, SJ1
Bataille, B; Delwail, V1
Hirose, M; Kuroda, Y1
Fehse, N; Gutensohn, K; Hassan, HT; Kröger, N; Krüger, W; Lölliger, C; Zander, AR; Zeller, W1
Hassan, HT; Hinz, T; Kroger, N; Zander, AR; Zeller, W1
Anderlini, P; Andersson, B; Braunschweig, I; Champlin, R; Claxton, D; Cleary, K; Donato, M; Folloder, J; Gajewski, J; Giralt, S; Hagemeister, F; Khouri, I; Körbling, M; Mehra, R; Molldrem, J; Przepiorka, D; Samuels, B; Ueno, NT; van Besien, K1
Hunter, N; Meyn, RE; Mirkovic, N; Story, MD1
Bashir, R; Batchelor, T; Chamberlain, M; Cowens, W; Glantz, MJ; Gutheil, JC; Howell, SB; Jaeckle, KA; LaFollette, S; Lyter, D; Maria, BL; Phuphanich, S; Rogers, LR; Rozental, JR; Schiffer, C; Shapiro, W; Swinnen, L; Thomas, D1
Devereux, S; Goldstone, AH; Ings, SJ; Leverett, D; Linch, DC; MacMillan, A; Watts, MJ1
Diehl, V; Draube, A; Engert, A; Josting, A; Reiser, M; Rueffer, U; Söhngen, D; Tesch, H; Wickramanayake, PD; Wolf, J1
Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H1
Bode, U; Deckert-Schlüter, M; Fischer, HP; Glasmacher, A; Kleinschmidt, R; Oehring, R; Pels, H; Schlegel, U1
Bruty, SJ; Duncombe, AS; George, P; Sweetenham, JW; Wyre, RM1
Klener, P; Procházka, B; Slabý, J; Trnený, M1
Bamberg, M; Brugger, W; Dichgans, J; Herrlinger, U; Kanz, L; Kortmann, RD; Schabet, M; Weller, M1
Chan, JK; Cheung, MM; So, JC; Wong, KF1
Biagi, E; Conter, V; Lazzareschi, I; Milani, M; Riccardi, R; Ruggiero, A; Sparano, P1
Bernard, M; Haegelen, C; Morandi, X; Riffaud, L1
Bode, U; Deckert, M; Fimmers, R; Fliessbach, K; Glasmacher, A; Helmstaedter, C; Kleinschmidt, R; Klockgether, T; Pels, H; Schlegel, U; Schmidt-Wolf, I; Van Roost, D1
Ariola, C; Cordone, I; Fazi, F; Fenu, S; Mandelli, F; Montefusco, E; Nanni, M; Petti, MC; Spadea, A; Spiriti, MA1
Croockewit, AJ; Fibbe, WE; Kingma, T; Uyl-de Groot, CA; van Agthoven, M; van Imhoff, GW; van Oers, MH; Vellenga, E; Verdonck, LF; Volkers, CP; Wijermans, PJ1
Hosomi, Y; Shibuya, M1
Bessell, EM; Byrne, P; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B; Petit, J; Verger, E; Villá, S1
Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M1
Alessandrino, EP; Arcaini, L; Astori, C; Bernasconi, P; Brusamolino, E; Cairoli, R; Calatroni, S; Colombo, AA; Gargantini, L; Iacona, I; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G; Regazzi, MB1
Carpenito, G; Kurtz, I1
Canellos, GP; Chaffey, JT; Hellman, S; Moloney, WC; Rosenthal, DS; Skarin, AT1
Coltman, CA; Jones, SE; Luce, JK; McKelvey, EM; Moon, TE1
Ekert, H; Lubitz, L1
Koelmel, HW; Weizsaecker, M1
Portlock, CS; Rosenberg, SA1
Bartolucci, AA; Dorfman, RF; Durant, JR; Gams, RA1
Sweet, DL; Ultmann, JE1
Bodey, GP; Rodriguez, V1
Burchenal, JH; Currie, VE; Krakoff, IH; Mackey, RW; Tan, CT; Wong, PP; Young, CW1
Bonmassar, E; Fioretti, MC; Giampietri, A; Goldin, A; Puccetti, P; Riccardi, C1
Grünwald, HW; Hirshaut, Y; Rosner, F1
Coltman, C; Gamble, JF; Gottlieb, JA; Grozea, PN; Gutterman, J; Haut, A; Jones, SE; Lane, M; McKelvey, EM; Moon, TE; Stephens, R; Talley, RW; Wilson, HE1
Kremer, WB1
Burchenal, J; D'angio, G; Exelby, P; Fang, S; Lieberman, P; Murphy, ML; Wollner, N1
Kaplan, HS; Rosenberg, SA1
Chan, YK; Dorfman, R; Durant, JR; Loeb, V1
Burchenal, JH; D'Angio, GJ; Exelby, PR; Lieberman, PH; Murphy, ML; Wollner, N1
Kernbaum, S1
Burchenal, JH; D'Angio, G; Exelby, P; Lieberman, PH; Murphy, ML; Wollner, N1
Chabner, BA; Duffey, PL; Longo, DL; Urba, WJ; Wilson, WH; Wittes, R1
Ashihara, E; Fujita, N; Goto, H; Inaba, T; Ito, K; Murakami, S; Okawa, K; Oku, N; Shimazaki, C; Tsuji, H1
Andrykowski, MA; Brady, MJ; Gregg, ME; Henslee-Downey, PJ; Lamb, DG; Schmitt, FA1
Amadori, S; Guglielmi, C; Mandelli, F; Martelli, M; Papa, G1
Janmohammed, RM; Leyland, MJ; Long, SG; Macdonald, DF; Milligan, DW; Smith, AG1
Chandler, C; Devine, S; Geller, RB; Larson, RA; Myers, S; O'Toole, K; Park, CL; Topper, RL; Williams, SF1
Cersosimo, RJ1
Brambilla Pisoni, G; Calloni, MV; Montalbetti, L; Trotti, G1
Agur, Z; Arnon, R; Schechter, B1
Chang, SC; Hsu, JR; Perng, RP1
Akerman, S; Chan, K; Dantis, E; DeAngelis, LM; Kreis, W1
Bulgarini, B; De Vecchis, L; Giuliani, A; Turriziani, M1
Chan, WC; Krendel, DA; Stahl, RL1
Crocker, I; Dobbs, CK; Gordon, DS; Heffner, LT; Reynolds, R; Sternberg, P; Vogler, WR; Winton, EF1
Carpen, M; Cohen, JS; Daly, PF; Myers, CE; Sandler, D; Zugmaier, G1
Chiba, Y; Fujitsu, K; Hayashi, A; Kuwabara, T; Kyuma, Y; Oda, M; Sekido, K; Shinonaga, M; Yamaguchi, K; Yamashita, T1
Brandwein, JM; Callum, J; Keating, A; Scott, JG; Sutcliffe, SB1
Burns, LJ; Fyfe, MA; Ginder, GD; Gingrich, RD; Wen, BC1
Baume, D; Carde, P; Droz, JP; Gilles, E; Hayat, M; Moran, A; Ostronoff, M; Pico, JL; Zambon, E1
Barth, RF; Groscurth, P; Hengartner, H; Langhals, H; Schott, H; Schwendener, RA; Trüb, T1
Friedenberg, WR; Norfleet, RG; Siemers, RF1
Madewell, BR1
Bron, D; Stryckmans, P; Vandenheule, B1
Archimbaud, E; Berger, F; Bryon, PA; Coiffier, B; Extra, JM; Ffrench, M; Fiere, D; Gentilhomme, O; Guyotat, D; Magaud, JP1
Anderson, T; Baumann, MA; Hande, KR; Ritch, PS; Topping, TM; Williams, GA1
Borri-Voltattorni, C; Dominici, P; Fioretti, MC; Fuschiotti, P; Puccetti, P; Romani, L1
Deyton, L; Gill, PS; Krailo, M; Levine, AM; Loureiro, C; Meyer, P; Rarick, MU; Rasheed, S1
Bentley, DP; Campbell, IA; Green, AR; Poynton, C1
Bernard, P; Boiron, JM; Marit, G; Reiffers, J; Rice, A; Vezon, G1
Haimovich, J; Hurwitz, E1
Cuthbert, RJ; Parker, AC; Sheehan, T1
Armata, J; Bogusławska-Jaworska, J; Daszkiewicz, P; Dłuzniewska, A; Kazanowska, B; Koehler, M; Matysiak, M; Ochocka, M; Pietras, W; Rodziewicz-Magott, B1
Appelbaum, FR; Bigelow, CL; Buckner, CD; Clift, RA; Fefer, A; Petersen, FB; Sanders, JE; Storb, R; Sullivan, KM; Weiden, PL1
Dalton, J; Friedman, AH; Strauchen, JA1
Kopper, L; Pogany, G; Sasvári-Székely, M; Soóki-Tóth, A; Spasokukotskaja, T; Staub, M1
Bankert, RB; Ghosh, SK; Jou, YH; Mayhew, E; Yokota, S1
Avramis, VI; Coates, TD; Lenarsky, C; Ozkaynak, MF; Parkman, R; Sato, JK; Weinberg, KI; Willoughby, ML1
Cousar, JB; Greco, FA; Greer, JP; Hainsworth, JD; Stein, RS; Wolff, SN1
Cabanillas, F; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Rodriguez, MA; Swan, F; Velasquez, WS1
Blaise, D; Gaspard, MH; Gastaut, JA; Maraninchi, D; Michel, G; Novakovitch, G; Rossi, JF; Stoppa, AM; Tubiana, N; Weiller, PJ1
Esumi, N; Fujiwara, F; Hashida, T; Ikushima, S; Imashuku, S; Ishii, T; Morioka, Y; Okano, S; Todo, S; Yoshihara, T1
Giannone, L; Greco, FA; Hainsworth, JD1
Bizzi, B; De Stefano, V; Leone, G; Marra, R; Pagano, L1
Cabanillas, F; Hagemeister, FB; McLaughlin, P; Redman, JR; Rodriguez, MA; Velasquez, WS; Yung, WK1
Hatae, Y; Hatayama, Y; Nakadate, H; Takeda, T1
Huijgens, PC; Ossenkoppele, GJ; Reijneke, RM; Thomas, LL; van der Lelie, J; Wijngaarden, MJ1
Cheung, NK; Coccia, PF; Gordon, EM; Herzig, RH; Novak, L; Shina, D; Strandjord, SE; Warkintin, PI1
Cabanillas, F; Fridrik, M; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Salvador, P; Swan, F; Tucker, S; Velasquez, WS1
Bernasconi, C; Brusamolino, E; Canevari, A; Inverardi, D; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G1
Bennett, CL; Bitran, JD; Kalokhe, U; Karesh, J; Putterman, A; Recant, W; Shapiro, CM1
Baer, MR; Flexner, JM; Greer, JP; Hainsworth, JD; Stein, RS; Wolff, SN1
Anderson, CC; Cawley, JC; Goldstone, AH; Harper, PG; Jelliffe, AM; Jones, M; Linch, DC; Machin, SJ; McLennan, KA; Souhami, RL1
Colly, LP; Peters, WG; Willemze, R1
Appelbaum, FR; Buckner, CD1
Lampkin, BC; Wong, KY1
Armitage, JO; Bierman, PJ; Gingrich, RD; Klassen, LW; Kumar, PP; Smith, DM; Weisenburger, DD1
Cassileth, PA; Gale, RP1
Adelstein, DJ; Brown, RA; Cassileth, PA; Coccia, PF; Herzig, GP; Herzig, RH; Hines, JD; Lazarus, HM; Strandjord, S; Wolff, SN1
Amaki, I; Hattori, K; Hirota, Y; Hoshino, A; Ichimaru, M; Ito, M; Kimura, I; Kimura, K; Maekawa, T; Ohno, R1
Bertino, JR; Odujinrin, OO1
Doi, S; Hara, J; Ishihara, S; Kawa, K; Tomita, K; Yabuuchi, H; Yumura, K1
Abromowitch, M; Dahl, GV; Kalwinsky, DK; Look, AT; Mirro, J; Murphy, SB; Ochs, J; Pui, CH; Rivera, G1
Lie, SO; Slørdahl, S1
Fujita, N; Haruyama, H; Ijichi, H; Nakagawa, M; Nakanishi, S; Nishio, A; Shimazaki, C1
Akashi, M; Furukawa, Y; Ikeda, K; Komatsu, N; Muroi, K; Ohsaka, A; Ohta, M; Suda, K; Takeda, K; Yoshida, M1
Ettinger, LJ; Jones, GR1
Dabich, L; Ensminger, WD; LoBuglio, AF; Wheeler, RH; Zuckerman, KS1
Brambilla, P; Mocarelli, P; Neri, MG; Pessina, A1
Gaynor, ER; Golomb, HM; Sweet, DL; Ultmann, JE1
Boyett, J; Crist, W; Doering, EJ; Hvizdala, E; Pullen, J; Ruymann, F; Steuber, CP; Sullivan, MP; Trueworthy, R1
Seeber, S1
Gassmann, W; Löffler, H; Schmitz, N1
Cheung, NK; Coccia, PF; Gordon, EM; Graham-Pole, J; Gross, S; Herzig, RH; Lazarus, HM; Spitzer, TR; Strandjord, SE; Warkentin, PI1
Coccia, PF; Herzig, GP; Herzig, RH; Lazarus, HM; Wolff, SN1
Cazellas, P; David, R; Douay, L; Gorin, NC; Jansen, J; Laporte, JP; Lopez, M; Rio, B; Stachowiak, J; Zittoun, R1
Lemerle, J1
Inoh, A; Kajitani, T; Kamiya, K; Seyama, T; Yanagihara, K; Yokoro, K1
Barnett, MJ; Butler, MG; Ganesan, TS; Lister, TA; Richards, MA; Rohatiner, AZ; Slevin, ML; Smith, BF; Waxman, JH1
Arakawa, S; Esumi, N; Imashuku, S; Todo, S1
Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T1
Anderson, T; Frick, JC; Hansen, RM; Ritch, PS1
Cohen, A; Ullman, B1
Amadori, S; Anselmo, AP; Biagini, C; Cimino, G; Guglielmi, C; Mandelli, F; Papa, G; Ruco, LP1
Barnett, MJ; Dhaliwal, HS; Gallagher, CJ; Lister, TA; Richards, MA; Rohatiner, AZ; Waxman, JH1
Adelstein, DJ; Herzig, RH; Hines, JD; Lazarus, HM1
Anderson, J; Green, MR; Schilsky, RL1
Glynn, JP; Goldberg, AI; Goldin, A; Kende, M; Mantel, N1
Fortuny, IE; Kennedy, BJ; Theologides, A; Weiss, R1
Ablashi, DV; Dienhardt, F; Falk, L; Klein, G; Pearson, G; Rabin, H; Rabson, A; Wolfe, L1
Hays, EF1
Ablashi, DV; Adamson, RH; Cicmanec, JL; Dalgard, DW1
Sambrook, J; Shatkin, AJ1
Bergsagel, DE1
Schabel, FM; Skipper, HE1
Jordan, GW; Merigan, TC; Stevens, DA; Waddell, TF1
Karran, P1
Fortner, CL; Greene, WH; Schimpff, SC; Wiernik, PH1
Davies, DA1
Benoy, CJ; Elson, LA; Jones, M; Schneider, R1
Cheeks, JB; Laster, WR; Schabel, FM; Skipper, HE; Trader, MW1
Dedrick, RL; Forrester, DD; Ho, DH1
Frei, E; Goldin, A; Schabel, FM1
Canellos, GP; O'Connell, M; Rosenoff, SH; Wiernik, PH1
Bax, I; Greenberg, P; Mara, B; Schrier, S1
Crowther, D1
Bodey, GP; Freireich, EJ; Rodriguez, V1
Carter, SK1
Berchenal, J1
Knospe, WH1
Gutterman, JU; Hersh, EM; Mavligit, GM; Reed, RC1
Barranco, SC; Drewinko, B; Ho, DH1
Cikes, M; Klein, G1
Beyer, R; Forster, W; Maidhof, A; Müller, WE; Zahn, RK1
Frei, E; Gottlieb, JA; Gutterman, JU; McCredie, KB; Rodriguez, V1
Tungsubutra, K1
Harrap, KR; Tattersall, MH1
Nixon, DD; Ultmann, JE1
Morrone, G1
Fairley, GH1
Ota, K1
Benoy, CJ; Elson, LA; Schneider, R1
Müller, WE; Sögtrop, HH; Yamazaki, ZI; Zahn, RK1
White, LP1
Laster, WR; Schabel, FM; Skipper, HE; Trader, MW1
Bruce, DL; Bruce, WR; Lin, HS1
Bruce, WR; Meeker, BE; Powers, WE; Valeriote, FA1
Burns, SL; Savel, H1

Reviews

33 review(s) available for cytarabine and Lymphoma

ArticleYear
[Chemotherapy using gemcitabine hydrochloride for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:11

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Deoxycytidine; Gemcitabine; Humans; Lymphoma; Practice Guidelines as Topic

2013
The role of additional radiotherapy for primary central nervous system lymphoma.
    The Cochrane database of systematic reviews, 2014, Jun-16, Issue:6

    Topics: Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Early Termination of Clinical Trials; Humans; Lymphoma; Methotrexate; Randomized Controlled Trials as Topic

2014
Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.
    International journal of nanomedicine, 2008, Volume: 3, Issue:4

    Topics: Antimetabolites, Antineoplastic; Capsules; Clinical Trials as Topic; Cytarabine; Humans; Injections, Spinal; Leukemia; Liposomes; Lymphoma; Meningitis; Treatment Outcome

2008
Primary central nervous system lymphoma: recent progress, many remaining questions.
    Current opinion in oncology, 2009, Volume: 21, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Rituximab

2009
Treatment approaches for primary CNS lymphomas.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Humans; Lymphoma; Methotrexate; Prognosis; Radiotherapy; Randomized Controlled Trials as Topic; Stem Cell Transplantation

2010
[Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:14

    Topics: Age Factors; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Ki-1 Antigen; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Precision Medicine; Prognosis; Pyrazines; Risk Factors; Rituximab; Survival Rate; Waldenstrom Macroglobulinemia

2011
Management of leptomeningeal malignancy.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7

    Topics: Adenocarcinoma; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Arachnoid Cysts; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Delayed-Action Preparations; Enzyme Inhibitors; Humans; Injections, Intravenous; Injections, Spinal; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Palliative Care; Randomized Controlled Trials as Topic; Thiotepa; Topoisomerase I Inhibitors; Topotecan

2005
Secondary central nervous system lymphoma.
    International journal of hematology, 2006, Volume: 84, Issue:2

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Lymphoma; Male; Recurrence; Rituximab; Stem Cell Transplantation

2006
Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:2

    Topics: Animals; Cytarabine; Humans; Leukemia; Liposomes; Lymphoma; Meningitis; Randomized Controlled Trials as Topic

2008
[Neurological problems in malignant hemopathies in children. II. Neurotoxicity of antiblastic drugs and radiotherapy].
    Minerva pediatrica, 1982, Jun-15, Volume: 34, Issue:11

    Topics: Antineoplastic Agents; Asparaginase; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Humans; Infant; Leukemia; Lymphoma; Methotrexate; Radiotherapy; Vincristine

1982
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Salvage Therapy; Vinblastine; Vincristine

1995
Intrathecal chemotherapy with antineoplastic agents in children.
    Paediatric drugs, 2001, Volume: 3, Issue:4

    Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Blood-Brain Barrier; Cerebellar Neoplasms; Cerebrospinal Fluid; Child; Cytarabine; Humans; Injections, Spinal; Lymphoma; Medulloblastoma; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thiotepa

2001
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphoma; Mesna; Methylprednisolone; Mitoxantrone

2001
The place of radiation therapy in the treatment of non-Hodgkin's lymphomas.
    Cancer, 1977, Volume: 39, Issue:2 Suppl

    Topics: Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymph Nodes; Lymphoma; Male; Methotrexate; Prednisone; Remission, Spontaneous; Time Factors; Vincristine

1977
Chemotherapy of non-Hodgkin lymphoma: the diffuse types.
    Antibiotics and chemotherapy, 1978, Volume: 24

    Topics: Antineoplastic Agents; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Leucovorin; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasms; Prednisone; Remission, Spontaneous; Vincristine

1978
Approaches to the treatment of acute leukemia and lymphoma in adults.
    Seminars in hematology, 1978, Volume: 15, Issue:3

    Topics: Acute Disease; Adult; Animals; BCG Vaccine; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Environment, Controlled; Humans; Immunotherapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Mice; Prednisone; Vincristine

1978
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapy.
    Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma; Methotrexate; National Institutes of Health (U.S.); Prednisone; United States; Vincristine

1992
Idarubicin: an anthracycline antineoplastic agent.
    Clinical pharmacy, 1992, Volume: 11, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Cytarabine; Drug Labeling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1992
Canine lymphoma.
    The Veterinary clinics of North America. Small animal practice, 1985, Volume: 15, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Cytarabine; Dog Diseases; Dogs; Drug Combinations; Lymph Nodes; Lymphoma; Palliative Care; Prednisone; Vincristine

1985
[Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Revue medicale de Bruxelles, 1985, Volume: 6, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Vincristine

1985
Overview of the clinical relevance of autologous bone marrow transplantation.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous

1986
Indications for and benefits of intensive therapies in treatment of childhood cancers.
    Cancer, 1986, Jul-15, Volume: 58, Issue:2 Suppl

    Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Methotrexate; Neoplasms; Osteosarcoma; Risk; Sarcoma, Ewing

1986
Amsacrine: a review.
    Leukemia research, 1986, Volume: 10, Issue:11

    Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Humans; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma

1986
An assessment of massive-dose chemotherapy of malignant disease.
    Canadian Medical Association journal, 1971, Jan-09, Volume: 104, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Division; Cyclophosphamide; Cytarabine; Female; Fluorouracil; Humans; Leukemia L1210; Leukemia, Lymphoid; Lymphoma; Melphalan; Mercaptopurine; Methotrexate; Mice; Multiple Myeloma; Neoplasms; Nitrogen Mustard Compounds; Prednisone; Pregnancy; Time Factors; Trophoblastic Neoplasms; Vinblastine

1971
Combination chemotherapy for lymphomas and leukemias.
    Disease-a-month : DM, 1973

    Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Hodgkin Disease; Humans; Immunotherapy; Infections; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Mercaptopurine; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Vincristine

1973
An overview of the status of the nitrosoureas in other tumors.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:3

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Melanoma; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Vincristine

1973
[Achievements in the treatment of leukemia and lymphoma].
    Klinicheskaia meditsina, 1973, Volume: 51, Issue:6

    Topics: Acute Disease; Animals; Antineoplastic Agents; Burkitt Lymphoma; Chemical Phenomena; Chemistry; Cytarabine; Drug Therapy, Combination; Humans; Immunotherapy; Leukemia; Lymphoma; Methods; Remission, Spontaneous; Time Factors

1973
Malignant lymphoma. 2. Therapy.
    Postgraduate medicine, 1974, Volume: 55, Issue:5

    Topics: Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Vincristine

1974
Immunochemotherapy of human cancer.
    Seminars in oncology, 1974, Volume: 1, Issue:4

    Topics: Acute Disease; Adjuvants, Immunologic; Adult; Animals; Antineoplastic Agents; BCG Vaccine; Cytarabine; Humans; Immunosuppressive Agents; Immunotherapy; Leukemia L1210; Lymphoma; Melanoma; Mice; Neoplasms; Neoplasms, Experimental; Prednisone; Vincristine

1974
The therapy of lymphoma.
    Seminars in hematology, 1969, Volume: 6, Issue:4

    Topics: Adrenal Cortex Hormones; Asparaginase; Bone Marrow Diseases; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Fever; Humans; Hydrazines; Infections; Kidney Failure, Chronic; Lymphoma; Mechlorethamine; Splenectomy; Vinblastine; Vincristine

1969
[Cytostatic chemotherapy of neoplasms in children].
    La Pediatria, 1971, Volume: 79, Issue:1

    Topics: Adrenal Cortex Hormones; Aminopterin; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Fluorouracil; Humans; Leukemia; Lymphoma; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Sarcoma; Vinblastine; Vincristine

1971
Combination chemotherapy in malignant diseases.
    Journal of the Royal College of Physicians of London, 1971, Volume: 5, Issue:2

    Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosine; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Immunotherapy; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine

1971
Multiple combination therapy in cancer chemotherapy in Japan.
    Gan, 1969, Volume: 60, Issue:3

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chloroquine; Cyclophosphamide; Cytarabine; Drug Synergism; Fluorouracil; Humans; Japan; Leukemia; Lymphoma; Mercaptopurine; Mitomycins; Neoplasms; Podophyllin; Prednisolone; Thiotepa; Vincristine; Vitamin K 1

1969

Trials

96 trial(s) available for cytarabine and Lymphoma

ArticleYear
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
    American journal of hematology, 2022, Volume: 97, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Decitabine; Humans; Leukemia, Myeloid, Acute; Lymphoma; Vorinostat

2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
    Leukemia, 2022, Volume: 36, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Quality of Life; Rituximab; Thiotepa; Transplantation, Autologous

2022
Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study.
    BMJ open, 2023, 04-24, Volume: 13, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Cytarabine; Humans; Lymphoma; Methotrexate; Multicenter Studies as Topic; Prospective Studies; Rituximab; Treatment Outcome; Vincristine

2023
Impact of the Conditioning Regimen Dose Intensity Before Autologous Stem Cell Transplantation on the Pulmonary Function Test Abnormalities in Patients With Lymphoma and Multiple Myeloma: Single Center Experience.
    Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Respiratory Function Tests; Retrospective Studies; Survival Rate; Transplantation Conditioning

2020
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma.
    Neurology, 2020, 12-08, Volume: 95, Issue:23

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Karnofsky Performance Status; Lymphoma; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Survival Analysis

2020
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients.
    Journal of neuro-oncology, 2021, Volume: 151, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Survival Rate; Venous Thromboembolism

2021
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
    Journal of neuro-oncology, 2021, Volume: 152, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy, Adjuvant; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Mental Status and Dementia Tests; Methotrexate; Middle Aged; Neurosurgical Procedures; Prognosis; Risk Factors; Rituximab

2021
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
    Journal of cancer research and clinical oncology, 2022, Volume: 148, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy

2022
A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine.
    Journal of clinical and experimental hematopathology : JCEH, 2017, Oct-12, Volume: 57, Issue:2

    Topics: Aftercare; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Rituximab; Survival Rate

2017
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial.
    Journal of neuro-oncology, 2018, Volume: 140, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Proto-Oncogene Proteins c-bcl-6; Teniposide; Treatment Outcome; Young Adult

2018
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:2

    Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Sirolimus; Survival Rate; Tacrolimus; Transplantation Conditioning

2019
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Nov-01, Volume: 31, Issue:31

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cranial Irradiation; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Rituximab; Time; Treatment Outcome; Vincristine

2013
The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2014, Volume: 55, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Dexamethasone; Dog Diseases; Dogs; Female; Lymphoma; Male; Melphalan; Recurrence; Retrospective Studies

2014
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Nov-01, Volume: 32, Issue:31

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Quality of Life; Survival Rate; Transplantation, Autologous; Treatment Outcome

2014
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
    The Lancet. Haematology, 2015, Volume: 2, Issue:6

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Prospective Studies; Quality of Life; Temozolomide; Treatment Outcome; Vincristine

2015
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:7

    Topics: Adult; Aged; Busulfan; Carmustine; Cyclophosphamide; Cytarabine; Drug Combinations; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Middle Aged; North America; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2016
A randomized, double-blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma.
    British journal of haematology, 2016, Volume: 174, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Management; Double-Blind Method; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Rituximab; Young Adult

2016
Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
    Ophthalmology, 2016, Volume: 123, Issue:9

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cerebellum; Cytarabine; Dacarbazine; Eye Neoplasms; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Survival Analysis; Temozolomide; Vincristine

2016
Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:12

    Topics: Adolescent; Adult; Aged; Carmustine; Cytarabine; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Myeloablative Agonists; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult

2016
Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 03-01, Volume: 28, Issue:3

    Topics: Adult; Age Factors; Aged; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome

2017
BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications.
    Bone marrow transplantation, 2017, Volume: 52, Issue:3

    Topics: Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Obesity; Podophyllotoxin; Prospective Studies; Transplantation Conditioning

2017
Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
    Bone marrow transplantation, 2009, Volume: 43, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Double-Blind Method; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Mouthwashes; Phytohemagglutinins; Pilot Projects; Placebos; Recombinant Proteins; Stomatitis

2009
Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of the Polish Acute Leukemia Group.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aged; Central Nervous System Neoplasms; Cytarabine; Drug Carriers; Female; Humans; Liposomes; Lymphoma; Male; Middle Aged; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Treatment Outcome; Young Adult

2009
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.
    Bone marrow transplantation, 2010, Volume: 45, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Feasibility Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Lymphoma; Male; Melphalan; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult

2010
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:4

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Societies, Medical; Time Factors; Vincristine; Young Adult

2010
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.
    British journal of cancer, 2010, Feb-16, Volume: 102, Issue:4

    Topics: Antimetabolites, Antineoplastic; Area Under Curve; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; International Cooperation; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Survival Analysis; Treatment Outcome

2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    The Lancet. Oncology, 2010, Volume: 11, Issue:11

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chi-Square Distribution; Cranial Irradiation; Cytarabine; Disease-Free Survival; Dose Fractionation, Radiation; Female; Germany; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome

2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Carmustine; Combined Modality Therapy; Cytarabine; Cytoprotection; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Mucositis; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Transplantation Conditioning; Transplantation, Autologous; Young Adult

2011
Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Feasibility Studies; Follow-Up Studies; Humans; Immunosuppression Therapy; Lymphoma; Methotrexate; Middle Aged; Organ Transplantation; Recurrence; Remission Induction; Transplantation; Treatment Outcome

2011
Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combination.
    The oncologist, 2011, Volume: 16, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pilot Projects; Salvage Therapy; Survival Rate; Thiotepa

2011
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Feb-15, Volume: 18, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Dacarbazine; Diffusion Magnetic Resonance Imaging; Etoposide; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Rituximab; Survival Analysis; Temozolomide; Treatment Outcome

2012
Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Melphalan; Middle Aged; Myeloablative Agonists; Podophyllotoxin; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2013
Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers.
    Bone marrow transplantation, 2013, Volume: 48, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Autografts; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neutropenia; Platelet Transfusion; Time Factors

2013
[Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].
    Zhonghua yi xue za zhi, 2002, Apr-10, Volume: 82, Issue:7

    Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Cell Movement; Child; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Lymphoma; Male; Middle Aged; Recombinant Proteins

2002
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
    Bone marrow transplantation, 2002, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Antigens, CD34; Antimetabolites, Antineoplastic; Blood Cell Count; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Middle Aged; Peripheral Blood Stem Cell Transplantation; Risk; Transplantation, Autologous

2002
Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma.
    International journal of hematology, 2003, Volume: 77, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome

2003
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jul-15, Volume: 21, Issue:14

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Belgium; Biopsy, Needle; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Spinal; Lomustine; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Neoplasm Staging; Probability; Procarbazine; Research; Risk Assessment; Survival Analysis; Treatment Outcome

2003
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Cancer, 2003, Sep-01, Volume: 98, Issue:5

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Bromodeoxyuridine; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Infusions, Intravenous; Lymphoma; Male; Methotrexate; Middle Aged; Treatment Outcome

2003
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Dec-15, Volume: 21, Issue:24

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisolone; Survival Analysis; Treatment Outcome

2003
The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen.
    Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Middle Aged; Pilot Projects; United Kingdom

2004
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
    The New England journal of medicine, 2004, Mar-25, Volume: 350, Issue:13

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine; Vindesine

2004
Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study.
    Bone marrow transplantation, 2004, Volume: 34, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multivariate Analysis; Retrospective Studies; Time Factors; Transplantation Conditioning; Transplantation, Autologous

2004
Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma.
    Bone marrow transplantation, 2004, Volume: 34, Issue:12

    Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Culture Techniques; Cells, Cultured; Cyclophosphamide; Cytarabine; Erythroid Precursor Cells; Humans; Integrin beta3; Lymphoma; Megakaryocytes; Melphalan; Peripheral Blood Stem Cell Transplantation; Platelet Membrane Glycoprotein IIb; Platelet Transfusion; Salvage Therapy; Thrombocytopenia; Thrombopoietin; Transplantation, Autologous; Treatment Outcome

2004
Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children.
    Pediatrics international : official journal of the Japan Pediatric Society, 2004, Volume: 46, Issue:5

    Topics: Acute Disease; Adolescent; Albuminuria; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Creatinine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Glomerular Filtration Rate; Humans; Kidney Tubules; Leukemia; Lymphoma; Methotrexate; Neoplasms; Neuroblastoma; Osteosarcoma; Proteinuria; Rhabdomyosarcoma; Vincristine

2004
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.
    Seminars in oncology, 2004, Volume: 31, Issue:6 Suppl 18

    Topics: Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Cytoprotection; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Middle Aged; Radiation-Protective Agents; Transplantation, Autologous

2004
First-line autologous stem cell transplantation in primary CNS lymphoma.
    European journal of haematology, 2005, Volume: 75, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompetence; Lymphoma; Male; Melphalan; Middle Aged; Neurotoxicity Syndromes; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Survival Rate; Transplantation, Autologous

2005
High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Aug-20, Volume: 24, Issue:24

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Cytarabine; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Germany; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Thiotepa; Transplantation, Autologous; Treatment Outcome

2006
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Transfusion, 2006, Volume: 46, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Transplantation, Autologous; Treatment Outcome

2006
A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
    Journal of neuro-oncology, 2007, Volume: 81, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Leukemia; Lymphoma; Male; Meningeal Neoplasms; Meningitis; Middle Aged

2007
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Bone marrow transplantation, 2006, Volume: 38, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous

2006
Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Paclitaxel; Recurrence; Stem Cells; Time Factors; Vinblastine; Vinorelbine

2006
Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial.
    Acta haematologica, 2006, Volume: 116, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Analysis; Topotecan

2006
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    European journal of haematology, 2007, Volume: 78, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Sepsis; Survival Rate; Transplantation, Autologous; Treatment Outcome

2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
    Bone marrow transplantation, 2007, Volume: 39, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Melphalan; Remission Induction; Transplantation Conditioning; Transplantation, Homologous

2007
Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.
    International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:9

    Topics: Adult; Aged; Alleles; Antimetabolites, Antineoplastic; Brain Chemistry; Central Nervous System Neoplasms; Cytarabine; Excitatory Amino Acids; Female; Homocysteine; Humans; Injections, Intravenous; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Neurotoxicity Syndromes; Pilot Projects; S-Adenosylmethionine; Statistics, Nonparametric; Time Factors

2007
[The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
    Folia haematologica (Leipzig, Germany : 1928), 1980, Volume: 107, Issue:1

    Topics: Bleomycin; Cell Division; Clinical Trials as Topic; Cytarabine; Doxorubicin; Fluorouracil; Hodgkin Disease; Humans; Hydroxyurea; Lymphoma; Neoplasm Invasiveness; Remission, Spontaneous; Vinca Alkaloids

1980
[New agents in the treatment of leukemia and lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:4 Pt 2

    Topics: Aclarubicin; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Clinical Trials as Topic; Cytarabine; Doxorubicin; Drug Evaluation; Humans; Infusions, Parenteral; Leukemia, Myeloid, Acute; Lymphoma; Middle Aged; Naphthacenes

1983
Sequential combination of systemic high-dose ara-C and asparaginase for the treatment of central nervous system leukemia and lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Clinical Trials as Topic; Cytarabine; Humans; Leukemia; Lymphoma; Male; Meningeal Neoplasms; Tomography, X-Ray Computed

1984
NHL-3 protocol. Six-drug combination chemotherapy for non-Hodgkin's lymphoma.
    Cancer, 1984, Jun-15, Volume: 53, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Leukocyte Count; Lymphoma; Male; Methotrexate; Middle Aged; Platelet Count; Prednisone; Vincristine

1984
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia

1995
[Lymphatic interventional radiology in the treatment of lymphatic neoplasmas].
    Zhonghua yi xue za zhi, 1995, Volume: 75, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphatic Metastasis; Lymphography; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radiography, Interventional; Stomach Neoplasms; Thiotepa

1995
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
    Investigational new drugs, 1994, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy

1994
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Prognosis; Recurrence; Remission Induction; Survival Rate

1994
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
    International journal of radiation oncology, biology, physics, 1993, Dec-01, Volume: 27, Issue:5

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Humans; Infant; Leukocyte Count; Lymphoma; Mediastinal Neoplasms; Meningeal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Survival Rate; Thioguanine; Vincristine

1993
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting

1993
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure

1995
Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma.
    Leukemia & lymphoma, 1995, Volume: 17, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Melphalan; Middle Aged

1995
Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients.
    Neurology, 1996, Volume: 46, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Eye Neoplasms; Female; Follow-Up Studies; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Thiotepa; Tomography, X-Ray Computed; Vincristine

1996
Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomas.
    Leukemia & lymphoma, 1996, Volume: 23, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cell Movement; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma; Melphalan; Middle Aged; Phospholipid Ethers; Risk Factors; Transplantation Conditioning

1996
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cytarabine; Delayed-Action Preparations; Female; Humans; Injections, Spinal; Lymphoma; Male; Meningitis, Aseptic; Middle Aged; Quality of Life; Survival Analysis; Treatment Outcome

1999
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients.
    British journal of cancer, 2000, Volume: 82, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Matched-Pair Analysis; Methylprednisolone

2000
Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue--a highly effective regimen for patients with refractory or relapsed indolent lymphoma.
    Leukemia & lymphoma, 2000, Volume: 37, Issue:1-2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2000
Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Neoplasma, 2000, Volume: 47, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma; Male; Melphalan; Nausea; Ondansetron; Serotonin Antagonists; Transplantation, Autologous; Tropisetron; Vomiting

2000
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
    British journal of haematology, 2001, Volume: 114, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chi-Square Distribution; Cisplatin; Cost-Benefit Analysis; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Recurrence; Statistics, Nonparametric; Survival Rate; Transplantation, Autologous

2001
Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-01, Volume: 20, Issue:1

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Diseases; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Spain; Survival Rate; United Kingdom; Vincristine

2002
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
    Cancer treatment reports, 1977, Volume: 61, Issue:6

    Topics: Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Time Factors; Vincristine

1977
Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience.
    Cancer treatment reports, 1977, Volume: 61, Issue:6

    Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Thioguanine; Time Factors; Vincristine

1977
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Cancer treatment reports, 1977, Volume: 61, Issue:6

    Topics: Carmustine; Cell Cycle; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine; Time Factors; Vincristine

1977
Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.
    Cancer treatment reports, 1979, Volume: 63, Issue:8

    Topics: Bone Marrow; Clinical Trials as Topic; Cytarabine; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Leukemia; Lymphoma; Middle Aged; Neoplasms; Nucleoside Deaminases; Pyrimidine Nucleosides; Tetrahydrouridine; Uridine

1979
Clinical trials in the non-Hodgkin's lymphomata at Stanford University experimental design and preliminary results.
    The British journal of cancer. Supplement, 1975, Volume: 2

    Topics: Antineoplastic Agents; Bone Marrow; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Humans; Lymph Nodes; Lymphoma; Prognosis; Thioguanine

1975
F-MACHOP in advanced aggressive lymphoma.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:3

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Fluorouracil; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1992
BEAM autografting in lymphoma--experience at one centre.
    Leukemia & lymphoma, 1992, Volume: 7 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Survival Rate; Transplantation, Autologous

1992
Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
    Bone marrow transplantation, 1992, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Graft vs Host Disease; Humans; Leukemia; Lymphoma; Male; Middle Aged

1992
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
    Bone marrow transplantation, 1989, Volume: 4, Issue:5

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Whole-Body Irradiation

1989
[Urotoxicity of enocitabine (BH-AC) and aclarubicin (ACM) in pediatric patients with hematological malignancies].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1988, Volume: 29, Issue:9

    Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Hematuria; Humans; Infant; Leukemia; Lymphoma; Male; Multicenter Studies as Topic; Retrospective Studies

1988
Combination intraventricular chemotherapy for meningeal neoplasia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lung Neoplasms; Lymphoma; Melanoma; Meningeal Neoplasms; Methotrexate; Thiotepa; Urinary Bladder Neoplasms

1986
Antithrombin III during high-dose cytosine arabinoside therapy with or without asparaginase.
    Acta haematologica, 1986, Volume: 75, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Cytarabine; Female; Humans; Leukemia; Liver; Lymphoma; Male; Middle Aged

1986
Results of induction and consolidation treatment with intermediate and high-dose ara-C and m-AMSA containing regimens in patients with primarily failed or relapsed acute leukemia and non-Hodgkin's lymphoma.
    Scandinavian journal of haematology. Supplementum, 1986, Volume: 44

    Topics: Adolescent; Adult; Aminoacridines; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Middle Aged

1986
Overview of the clinical relevance of autologous bone marrow transplantation.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous

1986
Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma.
    Cancer treatment reports, 1986, Volume: 70, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Pneumonia; Sepsis; Transfusion Reaction; Whole-Body Irradiation

1986
Amsacrine: a review.
    Leukemia research, 1986, Volume: 10, Issue:11

    Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Humans; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma

1986
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Cancer, 1985, Jan-15, Volume: 55, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Meningeal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Thioguanine; Vincristine

1985
Treatment of B-cell non-Hodgkin's malignant lymphomas of childhood in Europe: recent and on-going studies.
    IARC scientific publications, 1985, Issue:60

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Lymphoma; Methotrexate; Neoplasm Staging; Prednisone; Vincristine

1985
Central nervous system toxicity of high-dose cytosine arabinoside.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Cerebellar Diseases; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Epilepsy, Tonic-Clonic; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Nystagmus, Pathologic; Syndrome; Tremor

1985
Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial.
    The New England journal of medicine, 1973, Oct-25, Volume: 289, Issue:17

    Topics: Antibody Formation; Blood Cell Count; Clinical Trials as Topic; Complement Fixation Tests; Cytarabine; Herpes Zoster; Herpesvirus 3, Human; Hodgkin Disease; Humans; Infusions, Parenteral; Interferons; Lymphoma; Placebos; Time Factors

1973
Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trial.
    The Journal of infectious diseases, 1974, Volume: 130, Issue:6

    Topics: Clinical Trials as Topic; Cytarabine; Herpes Zoster; Herpesvirus 3, Human; Hodgkin Disease; Humans; Infusions, Parenteral; Lymphoma; Neoplasms; Placebos

1974

Other Studies

323 other study(ies) available for cytarabine and Lymphoma

ArticleYear
Guanosine diphosphate-L-fucose plasma: N-acetylglucosaminide fucosyltransferase as in index of bone marrow hyperplasia after chemotherapy.
    Cancer research, 1978, Volume: 38, Issue:1

    Topics: Antineoplastic Agents; Bone Marrow; Guanosine Diphosphate Fucose; Hexosyltransferases; Humans; Hyperplasia; Leukemia, Myeloid, Acute; Lymphoma; Remission, Spontaneous

1978
High D-index during mobilization predicts poor mobilization of CD34+ cells after anti-lymphoma salvage chemotherapy.
    Journal of clinical apheresis, 2022, Volume: 37, Issue:1

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Severity of Illness Index; Young Adult

2022
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
    Leukemia & lymphoma, 2022, Volume: 63, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Humans; Lymphoma; Outpatients; Oxaliplatin; Rituximab

2022
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome.
    Leukemia & lymphoma, 2022, Volume: 63, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Neutrophils; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous

2022
Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma.
    Hematology (Amsterdam, Netherlands), 2022, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Retrospective Studies; Semustine; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous

2022
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma.
    Leukemia & lymphoma, 2022, Volume: 63, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lomustine; Lymphoma; Methotrexate; Middle Aged; Procarbazine; Receptors, Thrombopoietin; Rituximab

2022
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
    Blood advances, 2022, 11-22, Volume: 6, Issue:22

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine

2022
Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis.
    Journal of neuro-oncology, 2022, Volume: 159, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cost-Benefit Analysis; Cytarabine; Humans; Lymphoma; Methotrexate; Retrospective Studies

2022
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.
    Transplantation and cellular therapy, 2023, Volume: 29, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carmustine; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Retrospective Studies; Transplantation, Autologous

2023
Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience.
    Haematologica, 2023, 04-01, Volume: 108, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma; Methotrexate; Rituximab; Thiotepa

2023
Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma.
    Scientific reports, 2022, 12-13, Volume: 12, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cost-Benefit Analysis; Cytarabine; Humans; Lymphoma; Methotrexate; Retrospective Studies; Rituximab; Treatment Outcome

2022
Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma.
    Leukemia & lymphoma, 2023, Volume: 64, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2023
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience.
    British journal of haematology, 2023, Volume: 201, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; COVID-19; Cytarabine; Humans; Ifosfamide; Lymphoma; Methotrexate; Pandemics; Prospective Studies; Rituximab; SARS-CoV-2; Vincristine

2023
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
    American journal of hematology, 2023, Volume: 98, Issue:6

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Temozolomide

2023
Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation.
    Transplantation and cellular therapy, 2023, Volume: 29, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Retrospective Studies; Thiotepa; Transplantation, Autologous

2023
Treatment of new-onset primary central nervous system lymphoma in elderly patients using RMPV chemotherapy: a single-institution experience.
    International journal of hematology, 2023, Volume: 118, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma; Methotrexate; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine

2023
The nutritional impact of CD19-targeted CAR-T therapy versus BEAM chemotherapy for adult patients with lymphoma.
    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, 2023, Volume: 36, Issue:5

    Topics: Adult; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Humans; Immunotherapy, Adoptive; Lymphoma; Mucositis; Nausea; Neoplasm Recurrence, Local; Receptors, Chimeric Antigen; Vomiting; Weight Loss

2023
The impact of overweight on renal toxicity in patients treated with dexamethasone, high-dose cytarabine, and cisplatin.
    International journal of hematology, 2020, Volume: 111, Issue:3

    Topics: Antineoplastic Agents; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Kidney Tubules; Lymphoma; Male; Overweight; Retrospective Studies; Risk Factors; Salvage Therapy

2020
Sodium N-lauryl amino acids derived from silk protein can form catanionic aggregates with cytarabine as novel anti-tumor drug delivery systems.
    Drug delivery, 2020, Volume: 27, Issue:1

    Topics: Amino Acids; Antimetabolites, Antineoplastic; Cations; Cell Line, Tumor; Cytarabine; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Lymphoma; Sericins; Silk; Surface-Active Agents

2020
BEAM conditioning regimen ensures better progression-free survival compared with TEAM but not with FEAM in lymphoma patients undergoing autologous stem cell transplant.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Progression-Free Survival; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous

2020
A comparison of bendamustine-EAM versus BEAM conditioning for autogolous stem cell transplant in lymphoma.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Stem Cell Transplantation; Transplantation Conditioning

2020
Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma-a retrospective study from the BSBMT (BEAM versus LEAM).
    Bone marrow transplantation, 2021, Volume: 56, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Humans; Lomustine; Lymphoma; Melphalan; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2021
Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
    Journal of feline medicine and surgery, 2021, Volume: 23, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cyclophosphamide; Cytarabine; Lomustine; Lymphoma; Methotrexate; Neoplasm Recurrence, Local

2021
Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens in Patients with Lymphoma.
    Hematology/oncology and stem cell therapy, 2022, Dec-23, Volume: 15, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Mitoxantrone; Transplantation Conditioning; Transplantation, Autologous

2022
Gastrointestinal and oncologic outcomes of pediatric gastrointestinal lymphoma following upfront resection or biopsy of bowel masses.
    Pediatric surgery international, 2021, Volume: 37, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Digestive System Surgical Procedures; Female; Humans; Ileal Neoplasms; Infant; Lymphoma; Male; Methotrexate; Retrospective Studies

2021
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.
    Oncogene, 2021, Volume: 40, Issue:23

    Topics: Animals; Antimetabolites, Antineoplastic; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxycytidine; Drug Resistance, Neoplasm; Equilibrative-Nucleoside Transporter 2; Exosomes; Gemcitabine; Humans; Lymphoma; Male; Mice; Mice, Inbred NOD; Mice, SCID; MicroRNAs; Primary Cell Culture; Tumor Microenvironment; Xenograft Model Antitumor Assays

2021
Primary Central Nervous System Lymphomas of the Brain: A Retrospective Analysis in a Single Institution.
    World neurosurgery, 2017, Volume: 103

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Burkitt Lymphoma; Cranial Irradiation; Craniotomy; Cytarabine; Cytoreduction Surgical Procedures; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neurosurgical Procedures; Prognosis; Retrospective Studies; Survival Rate; Young Adult

2017
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    Cancer, 2017, Aug-15, Volume: 123, Issue:16

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Busulfan; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Methotrexate; Middle Aged; Mucositis; Remission Induction; Retrospective Studies; Rituximab; Stem Cell Transplantation; Temozolomide; Thiotepa; Transplantation Conditioning; Transplantation, Autologous

2017
Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
    Oncotarget, 2017, Jul-25, Volume: 8, Issue:30

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Cytarabine; Dexamethasone; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Remission Induction; Rituximab; Survival Analysis; Treatment Outcome; Young Adult

2017
Incidence and prognostic significance of nephrotoxicity in patients receiving eshap as salvage therapy for lymphoma.
    Leukemia research, 2017, Volume: 58

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Incidence; Kaplan-Meier Estimate; Kidney Diseases; Lymphoma; Male; Methylprednisolone; Middle Aged; Outpatients; Prognosis; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Young Adult

2017
Interim
    Annals of hematology, 2017, Volume: 96, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Registries; Retrospective Studies; Survival Rate

2017
A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.
    Veterinary and comparative oncology, 2018, Volume: 16, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cytarabine; Dactinomycin; Dexamethasone; Female; Lymphoma; Male; Melphalan; Salvage Therapy

2018
Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients.
    Haematologica, 2018, Volume: 103, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Etoposide; Humans; Lymphoma; Remission Induction; Survival Analysis; Treatment Outcome

2018
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.
    British journal of haematology, 2018, Volume: 181, Issue:5

    Topics: Acute Disease; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Humans; Infusion Pumps; Leukemia; Lymphoma; Male; Melphalan; Middle Aged; Outpatients; Podophyllotoxin

2018
High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicity.
    European journal of haematology, 2018, Volume: 101, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult

2018
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018, Volume: 24, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Italy; Lymphoma; Male; Melphalan; Middle Aged; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2018
Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.
    Annals of hematology, 2019, Volume: 98, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Semustine; Survival Rate; Transplantation Conditioning

2019
Impact of diverse chemotherapeutic agents and external factors on activation of brown adipose tissue in a large patient collective.
    Scientific reports, 2019, 02-13, Volume: 9, Issue:1

    Topics: Adipose Tissue, Brown; Adult; Age Factors; Aged; Antineoplastic Agents; Body Mass Index; Cytarabine; Female; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sex Factors

2019
The economic impact of the transition from branded to generic oncology drugs.
    Current oncology (Toronto, Ont.), 2019, Volume: 26, Issue:2

    Topics: Antineoplastic Agents; Cetuximab; Cisplatin; Cost-Benefit Analysis; Cytarabine; Deoxycytidine; Dexamethasone; Drug Costs; Drugs, Generic; Erlotinib Hydrochloride; Gemcitabine; Humans; Lung Neoplasms; Lymphoma; Randomized Controlled Trials as Topic; Vinorelbine

2019
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
    Annals of hematology, 2019, Volume: 98, Issue:8

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cytarabine; Female; France; Humans; Lymphoma; Male; Melphalan; Middle Aged; Mucositis; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2019
[Our experience with the treatment of primary lymphomas of the central nervous system].
    Vnitrni lekarstvi, 2012, Volume: 58, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Rituximab; Survival Rate

2012
Fatal cisplatin overdose in the treatment of mediastinal lymphoma with the ESHAP regimen - analysis of the causes of the adverse drug event.
    Onkologie, 2013, Volume: 36, Issue:1-2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Overdose; Etoposide; Fatal Outcome; Female; Humans; Lymphoma; Mediastinal Neoplasms; Medication Errors; Methylprednisolone

2013
Which regimen is better for stem cell mobilization of lymphoma patients?
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2013, Volume: 48, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Procarbazine; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vinorelbine

2013
Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:7

    Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Outpatients; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2014
Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Temozolomide; Thrombocytopenia; Treatment Outcome; Young Adult

2014
Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Cytarabine; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Inhibitory Concentration 50; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Multiple Myeloma; Pyrimidines; Rituximab

2014
Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
    Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:6

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cytarabine; Dexamethasone; Female; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Middle Aged; Multimodal Imaging; Neoplasm Staging; Prognosis; Rituximab

2014
MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years.
    Neurology, 2014, Apr-15, Volume: 82, Issue:15

    Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma; Male; Methotrexate; Remission Induction; Thiotepa; Treatment Outcome

2014
Lymphomatosis cerebri: a treatable cause of rapidly progressive dementia.
    Journal of neurology, neurosurgery, and psychiatry, 2015, Volume: 86, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Dementia; Diffusion Magnetic Resonance Imaging; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiotherapy; Rituximab

2015
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose.
    Bone marrow transplantation, 2014, Volume: 49, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Transplantation Conditioning; Young Adult

2014
BEAM-conditioned autologous SCT improves the quality of response in Waldenström's macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre's 10-year experience.
    Bone marrow transplantation, 2014, Volume: 49, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Waldenstrom Macroglobulinemia

2014
Fotemustine, teniposide and dexamethasone in treating patients with CNS lymphoma.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dexamethasone; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Radiotherapy, Adjuvant; Teniposide; Young Adult

2014
Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation; Young Adult

2015
High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:8

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; France; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Transplantation, Autologous; Treatment Outcome

2015
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Disease-Free Survival; Female; Finland; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome

2015
Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12.
    Journal of the National Cancer Institute, 2015, Volume: 107, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Canada; Cisplatin; Clinical Trials as Topic; Cost Savings; Cost-Benefit Analysis; Cytarabine; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Hospital Charges; Hospital Costs; Humans; Lymphoma; Male; Middle Aged; Quality-Adjusted Life Years; Recurrence

2015
Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients.
    Archives of Iranian medicine, 2015, Volume: 18, Issue:9

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Retrospective Studies; Vincristine

2015
Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
    Veterinary and comparative oncology, 2017, Volume: 15, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Dog Diseases; Dogs; Female; Lymphoma; Male; Neutropenia; Recurrence; Retrospective Studies; Thrombocytopenia; Treatment Failure

2017
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT.
    Bone marrow transplantation, 2016, Volume: 51, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Registries; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa

2016
Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
    Annals of hematology, 2016, Volume: 95, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Poland; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult

2016
Nanoscale Quantifying the Effects of Targeted Drug on Chemotherapy in Lymphoma Treatment Using Atomic Force Microscopy.
    IEEE transactions on bio-medical engineering, 2016, Volume: 63, Issue:10

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Cytarabine; Elastic Modulus; Humans; Lymphoma; Microscopy, Atomic Force; Models, Biological; Nanomedicine; Rituximab; Single-Cell Analysis; Surface Properties; Tumor Microenvironment

2016
Fertility in premenopausal women post autologous stem cell transplant with BEAM conditioning.
    European journal of haematology, 2016, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Fertility; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Podophyllotoxin; Premenopause; Retrospective Studies; Transplantation Conditioning; Young Adult

2016
DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2016, Volume: 54, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Female; Filgrastim; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Recurrence; Transplantation, Autologous

2016
A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.
    Bone marrow transplantation, 2016, Volume: 51, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous

2016
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.
    Annals of hematology, 2016, Volume: 95, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Nausea; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult

2016
Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective.
    Cancer medicine, 2016, Volume: 5, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cost-Benefit Analysis; Cytarabine; Female; Follow-Up Studies; Health Care Costs; Hematopoietic Stem Cell Transplantation; Humans; Infections; Kaplan-Meier Estimate; Lymphoma; Male; Melphalan; Middle Aged; Outpatients; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Young Adult

2016
High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement.
    Acta haematologica, 2017, Volume: 137, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Rate

2017
Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.
    Cancer, 2017, 05-15, Volume: 123, Issue:10

    Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Case-Control Studies; Cranial Irradiation; Cytarabine; Female; Humans; Injections, Spinal; Leukemia; Lymphoma; Male; Methotrexate; Neoplasms; Neurotoxicity Syndromes; Orgasm; Personal Satisfaction; Psychosexual Development; Reproductive Health; Risk Factors; Sexual Partners; Surveys and Questionnaires; Survivors; Thiotepa; Young Adult

2017
Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
    Annals of hematology, 2008, Volume: 87, Issue:12

    Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Cohort Studies; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Spinal; Leukemia, Myeloid, Acute; Liposomes; Lymphoma; Male; Meningitis; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Transplantation, Homologous

2008
CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines.
    British journal of haematology, 2009, Volume: 144, Issue:2

    Topics: Cell Line, Tumor; Cell Membrane; Cytarabine; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lymphoma

2009
Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
    Veterinary and comparative oncology, 2008, Volume: 6, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Neoplasms; Cyclophosphamide; Cytarabine; Dog Diseases; Dogs; Doxorubicin; Female; Lymphoma; Male; Neoplasm Staging; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine

2008
Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cells through induction of apoptosis.
    Oncology reports, 2009, Volume: 21, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Humans; Inhibitory Concentration 50; Lymphoma; Phytotherapy; Plant Extracts

2009
Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma.
    Cancer, 2009, May-01, Volume: 115, Issue:9

    Topics: Adult; Aged; Cytarabine; Drug Evaluation; Female; Humans; Injections, Spinal; Liposomes; Lymphoma; Male; Meningeal Carcinomatosis; Middle Aged; Quality of Life; Retrospective Studies

2009
Progress in primary CNS lymphoma.
    Lancet (London, England), 2009, Oct-31, Volume: 374, Issue:9700

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Cytarabine; Humans; Lymphoma; Methotrexate; Randomized Controlled Trials as Topic

2009
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine

2010
[Inhibitive effect of artesunate on human lymphoblastic leukemia/lymphoma cells].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2009, Volume: 40, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Artesunate; Blood-Brain Barrier; Cell Line, Tumor; Cytarabine; Drug Synergism; Humans; Jurkat Cells; Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2009
ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma.
    Clinical lymphoma, myeloma & leukemia, 2010, Volume: 10, Issue:2

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cisplatin; Colony-Stimulating Factors; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Remission Induction; Rituximab

2010
New liposomal cytarabine formulation in CSF.
    Clinical laboratory, 2010, Volume: 56, Issue:1-2

    Topics: Aged; Cytarabine; Humans; Injections, Intraventricular; Injections, Spinal; Liposomes; Lymphoma; Male; Meningitis; Young Adult

2010
Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma.
    Journal of neuro-oncology, 2011, Volume: 103, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Liposomes; Lymphoma; Male; Middle Aged; Nervous System Diseases

2011
A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma.
    International journal of hematology, 2010, Volume: 92, Issue:4

    Topics: Aged; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Nitrosourea Compounds; Procarbazine; Retrospective Studies

2010
How important is whole brain radiotherapy for treatment of primary CNS lymphoma?
    The Lancet. Oncology, 2010, Volume: 11, Issue:11

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cytarabine; Disease-Free Survival; Humans; Ifosfamide; Lymphoma; Methotrexate; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Outcome

2010
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Investigational new drugs, 2012, Volume: 30, Issue:4

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Injections, Spinal; Leukemia; Liposomes; Lymphoma; Male; Meningeal Neoplasms; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult

2012
FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.
    Hematological oncology, 2012, Volume: 30, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Middle Aged; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2012
Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.
    Journal of neuro-oncology, 2011, Volume: 105, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thiotepa; Young Adult

2011
Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findings.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2012, Volume: 33, Issue:2

    Topics: Cauda Equina; Cytarabine; Humans; Immunosuppressive Agents; Leukocyte Common Antigens; Lymphoma; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Radiotherapy

2012
Comparison of total body irradiation before and after chemotherapy in pretreatment for hematopoietic stem cell transplantation.
    Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation; Young Adult

2012
CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.
    Pharmacogenomics, 2012, Volume: 13, Issue:4

    Topics: Child; Cytarabine; Cytidine Deaminase; Drug Combinations; Exons; Female; Homozygote; Humans; Lymphoma; Mercaptopurine; Methyltransferases; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Sequence Deletion

2012
High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nervous System; Temozolomide

2012
Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:11

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cytarabine; Humans; Leukemia; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Nitrogen Mustard Compounds

2012
A new modified prophylactic scheme against liposomal cytarabine-induced arachnoiditis in adult patients with lymphoma.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:4

    Topics: Adult; Arachnoiditis; Cytarabine; Humans; Liposomes; Lymphoma; Premedication

2013
Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
    JAMA ophthalmology, 2013, Volume: 131, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; British Columbia; Combined Modality Therapy; Cytarabine; Eye Neoplasms; False Positive Reactions; Female; Humans; Incidence; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Radiotherapy; Retinal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vitrectomy; Vitreous Body

2013
Cytometric evaluation of peripheral blood lymphocytes in dogs with lymphoma during chemotherapy.
    Journal of veterinary medicine. A, Physiology, pathology, clinical medicine, 2002, Volume: 49, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Cytarabine; Dog Diseases; Dogs; Female; Flow Cytometry; Immunophenotyping; Lymph Nodes; Lymphocytes; Lymphoma; Male; Prednisolone; Vincristine

2002
Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Dec-15, Volume: 20, Issue:24

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Humans; Lymphoma; Methotrexate; Procarbazine; Survival Rate; Vincristine

2002
HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.
    Leukemia, 2003, Volume: 17, Issue:11

    Topics: Apoptosis; Benzopyrans; Blast Crisis; Bone Marrow Cells; Cell Death; Cell Survival; Cytarabine; Drug Synergism; Enzyme Inhibitors; Genes, bcl-2; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Nitriles; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured

2003
THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
    Cancer research, 1964, Volume: 24

    Topics: Animals; Anti-Bacterial Agents; Antibodies; Antineoplastic Agents; Blood Cells; Carcinoma, Ehrlich Tumor; Cortisone; Cytarabine; Cytosine; Leukemia L1210; Leukemia, Experimental; Lymphoma; Mercaptopurine; Methotrexate; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 180

1964
Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
    Annals of hematology, 2003, Volume: 82, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Neutropenia; Recurrence; Remission Induction; Thrombocytopenia; Tomography, X-Ray Computed; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

2003
Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2003, Volume: 179, Issue:9

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Cause of Death; Combined Modality Therapy; Confidence Intervals; Cytarabine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Injections, Intravenous; Injections, Spinal; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Survival Analysis; Time Factors

2003
Use of chemotherapy for treatment of a mixed-cell thoracic lymphoma in a horse.
    Journal of the American Veterinary Medical Association, 2004, Mar-01, Volume: 224, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Female; Horse Diseases; Horses; Immunohistochemistry; Lymphoma; Pleural Effusion, Malignant; Prednisolone; Thoracic Neoplasms

2004
Intensive therapy for aggressive lymphoma.
    The New England journal of medicine, 2004, Jul-01, Volume: 351, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Lymphoma; Methotrexate; Prednisone; Stem Cell Transplantation; Vincristine

2004
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Bone marrow transplantation, 2004, Volume: 34, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Prognosis; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome

2004
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2004, Volume: 10, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artificial Gene Fusion; Bone Marrow Transplantation; Cell Line, Tumor; Combined Modality Therapy; Cytarabine; Cytidine Deaminase; Female; Genetic Therapy; Humans; Lymphoma; Methotrexate; Mice; Mice, SCID; Mutation; Retroviridae; Tetrahydrofolate Dehydrogenase; Transplantation, Heterologous

2004
Aggressive systemic mastocytosis mimicking sclerosing cholangitis.
    Haematologica, 2004, Volume: 89, Issue:9

    Topics: Abdominal Pain; Adrenal Cortex Hormones; Adult; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; Budd-Chiari Syndrome; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Clone Cells; Cytarabine; Diagnosis, Differential; Diarrhea; Fatal Outcome; Female; Flushing; Histamine H1 Antagonists; Humans; Idarubicin; Liver; Lymphoma; Mast Cells; Mastocytosis, Systemic; Mutation, Missense; Point Mutation; Prednisone; Proto-Oncogene Proteins c-kit; Recurrence

2004
[Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2004, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins

2004
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Bisbenzimidazole; Cell Line, Tumor; Colonic Neoplasms; Coloring Agents; Cytarabine; Dimerization; Dinucleoside Phosphates; Fluorescent Dyes; Fluorouracil; Humans; Inhibitory Concentration 50; Lymphoma; Propidium

2004
The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL).
    Journal of experimental & clinical cancer research : CR, 2004, Volume: 23, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Regression Analysis; Time Factors; Treatment Outcome; Vincristine

2004
Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.
    Haematologica, 2005, Volume: 90, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Bone Marrow Transplantation; Carmustine; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Male; Melphalan; Middle Aged; Multivariate Analysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous

2005
Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells.
    Leukemia research, 2005, Volume: 29, Issue:7

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytarabine; Dimerization; Floxuridine; Humans; Lymphoma; Phosphorylation

2005
Effect of notch ligands on in vitro sensitivity to chemo-therapeutic drugs in leukemia and lymphoma cells.
    Oncology reports, 2005, Volume: 14, Issue:3

    Topics: Antineoplastic Agents; Calcium-Binding Proteins; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Humans; Immunoblotting; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Jagged-1 Protein; Leukemia; Ligands; Lymphoma; Membrane Proteins; Mitoxantrone; NF-kappa B; Phosphorylation; Poly(ADP-ribose) Polymerases; Receptors, Notch; Recombinant Proteins; Serrate-Jagged Proteins; U937 Cells

2005
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
    Leukemia, 2005, Volume: 19, Issue:12

    Topics: Adenosine Triphosphate; Apoptosis; Cell Proliferation; Cytarabine; Drug Synergism; Energy Metabolism; Glycolysis; Humans; Leukemia; Lymphoma; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2005
[Two cases of malignant lymphoma with high fever and C-reactive protein (CRP) elevation after treatment with granulocyte colony-stimulating factor (G-CSF)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Recombinant Proteins; Rituximab; Vincristine

2006
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
    Investigational new drugs, 2007, Volume: 25, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Cytarabine; Depsipeptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Imatinib Mesylate; Irinotecan; K562 Cells; Leukemia; Lymphoma; Mercaptopurine; Piperazines; Pyrimidines; Time Factors

2007
Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphoma.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:5

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Middle Aged; Remission Induction; Retrospective Studies; Rituximab; Stem Cells

2007
[The standard treatments for patients with hematological malignancies in Japan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Multiple Myeloma; Prednisone; Rituximab; Survival Rate; Vincristine

2007
Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    American journal of ophthalmology, 2007, Volume: 144, Issue:1

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carotid Artery, Internal; Catheterization, Peripheral; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Pigment Epithelium of Eye; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Vertebral Artery

2007
[Comparison of salvage chemotherapy regimen ACES with ESHAP for refractory or relapsed malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation

2007
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Oct-20, Volume: 25, Issue:30

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Prospective Studies; Remission Induction; Rituximab; Treatment Outcome; Vincristine

2007
Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    American journal of ophthalmology, 2007, Volume: 144, Issue:6

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cyclophosphamide; Cytarabine; Etoposide; Fluorescein Angiography; Humans; Injections, Spinal; Lymphoma; Mannitol; Methotrexate; Pigment Epithelium of Eye; Retinal Diseases

2007
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cytarabine; Deoxycytidine; Drug Interactions; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Hydrazines; Idarubicin; Irinotecan; Leukemia; Lymphoma; Sulfonamides; Topotecan

2008
Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
    Biochemical pharmacology, 1967, Volume: 16, Issue:4

    Topics: Animals; Burkitt Lymphoma; Chromatography, Paper; Culture Techniques; Cytarabine; Cytosine Nucleotides; Drug Antagonism; Drug Synergism; Kidney; Leukemia L1210; Liver; Lymphoma; Mice; Nucleosides; Oxidation-Reduction; Thymidine; Uracil Nucleotides

1967
Clinical pharmacology and human antitumor activity of cytosine arabinoside.
    Cancer, 1967, Volume: 20, Issue:5

    Topics: Adenocarcinoma; Blood Platelets; Carcinoma, Squamous Cell; Cytarabine; Hemoglobinometry; Humans; Leukemia; Leukocyte Count; Lymphoma; Lymphoma, Non-Hodgkin

1967
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
    Gan no rinsho. Japan journal of cancer clinics, 1984, Volume: 30, Issue:9 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance; Fluorouracil; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Osteosarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Succinate Dehydrogenase; Vincristine

1984
[Chemotherapy of non-Hodgkin lymphoma with poor prognosis].
    Polskie Archiwum Medycyny Wewnetrznej, 1980, Volume: 64, Issue:2

    Topics: Antineoplastic Agents; Asparaginase; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Thioguanine; Vincristine

1980
Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy.
    Blood, 1982, Volume: 60, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Herpes Zoster; Humans; Immunoblastic Lymphadenopathy; Karyotyping; Leucovorin; Lymph Nodes; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine

1982
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
    The American journal of medicine, 1983, Volume: 74, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Radiography, Abdominal; Remission, Spontaneous; Time Factors; Vincristine

1983
[Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy].
    Presse medicale (Paris, France : 1983), 1983, Oct-08, Volume: 12, Issue:35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma; Male; Prednisolone; Prednisone; Prognosis; Teniposide; Thioguanine; Vincristine

1983
[High dose combination chemotherapy (AAABC) and autologous bone marrow transplantation for non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1983, Volume: 24, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Lymphoma; Male; Middle Aged; Nimustine; Nitrosourea Compounds

1983
[Non-Hodgkin's malignant lymphoma. Therapeutic value of autologous bone marrow transplantation].
    Presse medicale (Paris, France : 1983), 1983, Sep-10, Volume: 12, Issue:31

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Thioguanine

1983
Complement-induced entry o f membrane-impermeable material into living tumor cells: possibilities for chemotherapy.
    Clinical immunology and immunopathology, 1981, Volume: 18, Issue:2

    Topics: Animals; Cell Membrane Permeability; Complement System Proteins; Cytarabine; Diphosphonates; Erythrocyte Membrane; Guanosine Monophosphate; Guanosine Triphosphate; Lymphoma; Mice; Osmolar Concentration; Rabbits; Sucrose

1981
Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Humans; Lomustine; Lymphoma; Male; Risk; Thioguanine; Whole-Body Irradiation

1983
High-dose cytosine arabinoside in non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:11

    Topics: Adult; Aged; Bone Marrow; Cytarabine; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged

1983
Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Freezing; Hematopoiesis; Humans; Lomustine; Lymphoma; Prognosis; Thioguanine; Time Factors; Transplantation, Autologous; Whole-Body Irradiation

1984
High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Lymphoma; Male; Nervous System Neoplasms; Recurrence; Thioguanine

1984
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma.
    Leukemia research, 1984, Volume: 8, Issue:4

    Topics: Adolescent; Adult; Asparaginase; Cytarabine; Drug Therapy, Combination; Humans; Leukemia; Lymphoma

1984
Radiation recall supraglottitis. A hazard in head and neck chemotherapy.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1984, Volume: 110, Issue:9

    Topics: Cytarabine; Epiglottitis; Head and Neck Neoplasms; Humans; Laryngitis; Lomustine; Lymphoma; Male; Middle Aged; Radiation Injuries

1984
High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphoma.
    The American journal of medicine, 1984, Volume: 77, Issue:5

    Topics: Adult; Aged; Bone Marrow; Brain Neoplasms; Cytarabine; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Spinal Cord Neoplasms

1984
Increase of natural killer (NK) activity of mouse lymphocytes following in vitro treatment with cytosine-arabinoside.
    International journal of immunopharmacology, 1984, Volume: 6, Issue:5

    Topics: Animals; Cell Adhesion; Cell Line; Cell Survival; Cytarabine; Female; Killer Cells, Natural; Lymphocytes; Lymphoma; Male; Mice; Mice, Inbred C57BL; Spleen; Time Factors

1984
Evaluation of the LSA2L2 protocol for treatment of childhood non-Hodgkin's lymphoma. A report from the Polish Children's Leukemia/Lymphoma Study Group.
    The American journal of pediatric hematology/oncology, 1984,Winter, Volume: 6, Issue:4

    Topics: Abdominal Neoplasms; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Leukopenia; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Vincristine

1984
Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:9

    Topics: Cytarabine; Drug Administration Schedule; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma

1983
Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.
    Nihon Gan Chiryo Gakkai shi, 1984, Feb-20, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Child; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged

1984
Successful therapy of convoluted T-lymphoblastic lymphoma in the adult.
    Blood, 1983, Volume: 61, Issue:1

    Topics: Adolescent; Adult; Asparaginase; Brain; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Injections, Spinal; Lomustine; Lymphoma; Male; Mediastinum; Methotrexate; Middle Aged; Prednisone; T-Lymphocytes; Vincristine

1983
The cytarabine syndrome in an adult.
    Cancer treatment reports, 1983, Volume: 67, Issue:4

    Topics: Aged; Cytarabine; Humans; Lymphoma; Male; Syndrome; T-Lymphocytes

1983
Phase I trial of cytarabine and hydroxyurea.
    Cancer treatment reports, 1983, Volume: 67, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Child; Cytarabine; Drug Evaluation; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Hydroxyurea; Leukemia; Lymphoma; Male; Middle Aged; Skin Diseases

1983
Primary lymphoma of the brain: a case report and review of the literature.
    Journal of surgical oncology, 1984, Volume: 26, Issue:2

    Topics: Brain Neoplasms; Cytarabine; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis

1984
Thyroid dysfunction among long-term survivors of bone marrow transplantation.
    The American journal of medicine, 1982, Volume: 73, Issue:5

    Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Immunologic Deficiency Syndromes; Infant; Leukemia; Lymphoma; Male; Radiation Injuries; Thyroid Diseases; Thyroid Function Tests; Time Factors; Whole-Body Irradiation

1982
[Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Female; Hodgkin Disease; Humans; Immunoblastic Lymphadenopathy; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged

1982
Leptomeningeal lymphoma: perspectives on management.
    Cancer treatment reviews, 1981, Volume: 8, Issue:2

    Topics: Antineoplastic Agents; Arachnoid; Cytarabine; Humans; Injections, Spinal; Lymphoma; Meningeal Neoplasms; Methotrexate; Pia Mater; Thiotepa

1981
The clinical pharmacology of cytosine arabinoside.
    Haematology and blood transfusion, 1983, Volume: 28

    Topics: Cytarabine; Humans; Infusions, Parenteral; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Leukemia; Lymphoma

1983
A phase I-II study of combination therapy with thymidine and cytosine arabinoside.
    Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Child; Child, Preschool; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Lymphoma; Male; Middle Aged; Thymidine

1983
[Differential sensitivities of human malignant lymphoma cell lines to anti-cancer drugs].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1983, Volume: 24, Issue:4

    Topics: Antineoplastic Agents; Cell Differentiation; Cell Line; Cell Survival; Cytarabine; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Humans; In Vitro Techniques; Lymphoma

1983
Cytostatic drugs are without significant effect on digitoxin plasma level and renal excretion.
    Clinical pharmacology and therapeutics, 1982, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Digitoxin; Female; Heart Failure; Humans; Leukemia; Lymphoma; Male; Middle Aged; Prednisone; Procarbazine; Vincristine

1982
Results of LSA2-L2 therapy in 26 children with non-Hodgkin's lymphoma.
    Cancer, 1982, Dec-15, Volume: 50, Issue:12

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Lymphoma; Male; Mediastinum; Methotrexate; Vincristine

1982
The cytosine arabinoside (Ara-C) syndrome.
    Medical and pediatric oncology, 1981, Volume: 9, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Cytarabine; Female; Fever; Humans; Leukemia, Lymphoid; Lymphoma; Male; Pain; Syndrome

1981
A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Cancer research, 1982, Volume: 42, Issue:4

    Topics: Adolescent; Adult; Aged; Blood; Bone Marrow; Brain; Brain Neoplasms; Child; Cytarabine; Drug Evaluation; Eye; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Pilot Projects

1982
Use of cytosar in pediatric non-Hodgkin lymphoma.
    Medical and pediatric oncology, 1982, Volume: 10 Suppl 1

    Topics: Child; Cytarabine; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Lymphoma; Thioguanine

1982
Influence of Ara-C on effector activity of cytotoxic T-lymphocytes in vitro.
    Journal of immunopharmacology, 1981, Volume: 3, Issue:1

    Topics: Animals; Cytarabine; Cytotoxicity, Immunologic; Lymphoma; Mice; Neoplasms, Experimental; Spleen; T-Lymphocytes

1981
[Chemotherapy of malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine

1982
High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients.
    European journal of cancer, 1981, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Freezing; Hematopoiesis; Humans; Leukemia; Leukocyte Count; Lomustine; Lymphoma; Male; Middle Aged; Neoplasms; Platelet Count; Thioguanine; Transplantation, Autologous

1981
Uptake of cytosine arabinoside (Ara-C) by LSA lymphoma after irradiation in the stationary phase of growth.
    Radiology, 1982, Volume: 142, Issue:3

    Topics: Adult; Animals; Cell Line; Cell Survival; Cytarabine; Humans; In Vitro Techniques; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Time Factors

1982
Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo.
    British journal of cancer, 1982, Volume: 45, Issue:4

    Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Cell Survival; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance; Liposomes; Lymphoma; Methotrexate; Mice; Mice, Inbred CBA; Neoplasms, Experimental

1982
Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.
    British journal of cancer, 1982, Volume: 45, Issue:4

    Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cell Line; Cytarabine; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Liposomes; Lymphoma; Mice; Neoplasms, Experimental; Thymidine

1982
[Therapy of non-Hodgkin lymphomas].
    Minerva medica, 1982, Apr-07, Volume: 73, Issue:15

    Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Humans; Lymphoma; Methotrexate; Prednisone; Procarbazine; Thioguanine; Vincristine

1982
Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Cancer research, 1982, Volume: 42, Issue:7

    Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cell Division; Cell Line; Cells, Cultured; Cytarabine; DNA, Neoplasm; Humans; Hydroxyurea; Leukemia; Lymphoma; Phosphorylation; Thymidine

1982
Salvage chemotherapy for non-Hodgkin's lymphoma.
    Cancer treatment reports, 1982, Volume: 66, Issue:11

    Topics: Adult; Aged; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Lymphoma; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Thrombocytopenia

1982
Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines.
    Biochimica et biophysica acta, 1981, May-06, Volume: 643, Issue:2

    Topics: Animals; Biological Transport; Cell Line; Cytarabine; Dactinomycin; Female; Liposomes; Lymphoma; Mammary Neoplasms, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Phospholipids; Ribonucleosides; Tubercidin

1981
Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.
    British journal of cancer, 1980, Volume: 41, Issue:2

    Topics: Animals; Cytarabine; Dose-Response Relationship, Immunologic; Immune Sera; Immunization, Passive; Injections, Intraperitoneal; Injections, Intravenous; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Propionibacterium acnes

1980
[Intraventricular chemotherapy for treatment of meningeal dissemination from malignant neoplasms (author's transl)].
    No shinkei geka. Neurological surgery, 1980, Volume: 8, Issue:5

    Topics: Antineoplastic Agents; Cytarabine; Hydrocortisone; Injections, Intraventricular; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness

1980
On heterogeneity of non-Hodgkin's lymphomas as regards sensitivity to cytostatic drugs. An in vitro study.
    European journal of cancer, 1980, Volume: 16, Issue:5

    Topics: Cells, Cultured; Cytarabine; DNA, Neoplasm; Humans; Lymphoma; Melphalan; Prednimustine; Thymidine; Vincristine

1980
[Prognostic changes in juvenile abdominal non-Hodgkin's lympomas (NHL)].
    Schweizerische medizinische Wochenschrift, 1980, Jul-08, Volume: 110, Issue:27-28

    Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Male; Methotrexate; Prednisone; Prognosis; Thioguanine; Vincristine

1980
Serotherapy of a spontaneous mouse tumour.
    British journal of cancer, 1980, Volume: 41, Issue:5

    Topics: Animals; Cytarabine; Female; Immunization, Passive; Lymphoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental

1980
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
    Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 11

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms

1995
Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.
    Blood, 1993, Dec-15, Volume: 82, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Length of Stay; Leukapheresis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Vincristine

1993
High-dose chemotherapy and autologous peripheral stem cell transplantation in patients with relapsing malignant lymphomas--first experience in the Slovak Republic.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Lymphoma; Mitoxantrone; Salvage Therapy; Slovakia

1995
Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Stem cells (Dayton, Ohio), 1995, Volume: 13, Issue:3

    Topics: Adult; Antigens, CD; Antigens, CD34; Antigens, Differentiation, Myelomonocytic; Bone Marrow Cells; CD13 Antigens; Cell Separation; Colony-Forming Units Assay; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Receptor Protein-Tyrosine Kinases; Receptors, Colony-Stimulating Factor; Sialic Acid Binding Ig-like Lectin 3

1995
Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopterins; Bone Marrow Transplantation; Busulfan; Carmustine; Cells, Cultured; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Susceptibility; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Lymphoma; Male; Melphalan; Middle Aged; Monocytes; Neopterin; Podophyllotoxin; Respiratory Burst; Superoxides; Tumor Necrosis Factor-alpha; Whole-Body Irradiation

1995
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma.
    Bone marrow transplantation, 1995, Volume: 16, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cell Separation; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Lymphoma; Male; Middle Aged; Prognosis; Salvage Therapy

1995
[Peripheral blood stem cell transplantation in adult patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Blood Cell Count; Cell Separation; Chemotherapy, Adjuvant; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1993
[Appropriate administration of granulocyte colony stimulating factor for malignant lymphoma of the head and neck].
    Nihon Jibiinkoka Gakkai kaiho, 1993, Volume: 96, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Leukopenia; Lymphoma; Methotrexate; Prednisone; Teniposide; Vincristine

1993
Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product.
    British journal of cancer, 1993, Volume: 68, Issue:5

    Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Lymphoma; Male; Melphalan; Middle Aged; Salvage Therapy; Time Factors

1993
Viridans streptococcal bacteraemia in patients with neutropenia.
    Lancet (London, England), 1995, Jun-24, Volume: 345, Issue:8965

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Case-Control Studies; Cytarabine; Environment, Controlled; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Mouth; Neutropenia; Prospective Studies; Risk Factors; Saliva; Streptococcal Infections; Streptococcus

1995
Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study.
    Bone marrow transplantation, 1994, Volume: 14, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Transplantation, Autologous

1994
[Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Middle Aged; Nitrosourea Compounds

1994
Bone marrow transplantation in Iran.
    Bone marrow transplantation, 1994, Volume: 13, Issue:6

    Topics: Adolescent; Adult; Anemia, Aplastic; beta-Thalassemia; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Financing, Personal; Graft vs Host Disease; Humans; Insurance, Health, Reimbursement; Iran; Lymphoma; Male; Melphalan; Middle Aged; Transplantation, Autologous; Transplantation, Homologous

1994
Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation (ABSCT) recipients.
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:4

    Topics: Bone Marrow; Carmustine; Cells, Cultured; Colony-Forming Units Assay; Connective Tissue; Cyclophosphamide; Cytarabine; Etoposide; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Multiple Myeloma; Transplantation, Autologous; Whole-Body Irradiation

1994
Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma.
    Bone marrow transplantation, 1994, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Follicle Stimulating Hormone; Humans; Leydig Cells; Luteinizing Hormone; Lymphoma; Male; Melphalan; Spermatozoa; Transplantation, Autologous

1994
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
    Seminars in hematology, 1994, Volume: 31, Issue:2 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Mesna; Methylprednisolone Hemisuccinate; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate

1994
E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Lymphoma; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Treatment Outcome

1993
Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.
    Bone marrow transplantation, 1993, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Glomerular Filtration Rate; Hemolytic-Uremic Syndrome; Humans; Kidney; Lymphoma; Male; Middle Aged; Transplantation, Autologous; Whole-Body Irradiation

1993
A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Experimental hematology, 1995, Volume: 23, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukapheresis; Leukocyte Count; Leukocytes, Mononuclear; Lymphoma; Lymphoma, Non-Hodgkin; Macrophages; Male; Melphalan

1995
Effect of modulation of the transferrin receptor on gallium-67 uptake and cytotoxicity in lymphoma cell lines.
    British journal of cancer, 1996, Volume: 74, Issue:4

    Topics: Antineoplastic Agents; Biological Transport; Cell Cycle; Cell Division; Cell Line; Cell Survival; Cytarabine; Flow Cytometry; Gallium Radioisotopes; Gene Expression; Humans; Hydroxyurea; Lymphoma; Methotrexate; Receptors, Transferrin; Tumor Cells, Cultured; Tumor Stem Cell Assay

1996
G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphoma.
    Bone marrow transplantation, 1996, Volume: 18, Issue:2

    Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cold Temperature; Combined Modality Therapy; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin

1996
Peripheral blood stem cell support does not accelerate haemopoietic recovery from miniBEAM chemotherapy.
    Bone marrow transplantation, 1996, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged

1996
Seeking the nucleoside transporter.
    Nature medicine, 1997, Volume: 3, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Carrier Proteins; Cell Membrane; Cladribine; Cloning, Molecular; Cytarabine; Deoxycytidine; Erythrocytes; Gemcitabine; Glucose Transporter Type 1; Humans; Leukemia; Lymphoma; Membrane Proteins; Monosaccharide Transport Proteins; Nucleosides; Oocytes; Recombinant Proteins; Uridine; Vidarabine; Xenopus

1997
Long-term survival in primary CNS lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome

1998
Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma.
    Acta neurologica Scandinavica, 1998, Volume: 97, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Premedication; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

1998
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapy.
    American journal of hematology, 1998, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Tomography, X-Ray Computed; Vincristine

1998
[Chemotherapy of primary cerebral lymphoma].
    Neuro-Chirurgie, 1997, Volume: 43, Issue:6

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cytarabine; Humans; Injections, Spinal; Lymphoma; Methotrexate; Survival Rate; Treatment Outcome

1997
p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
    Cancer letters, 1998, Jul-17, Volume: 129, Issue:2

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cytarabine; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, Retinoblastoma; Humans; Leukemia; Lymphoma; Multidrug Resistance-Associated Proteins; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Neoplasm; Transcription Factors; Tumor Cells, Cultured; Vincristine; WT1 Proteins

1998
Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients.
    British journal of haematology, 1998, Volume: 102, Issue:4

    Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colony-Forming Units Assay; Cytarabine; Dexamethasone; Etoposide; Female; Filgrastim; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Lymphoma; Male; Melphalan; Middle Aged; Recombinant Proteins; Retrospective Studies

1998
Factors influencing platelet recovery after autologous transplantation of G-CSF-mobilized peripheral blood stem/progenitor cells following myeloablative therapy in 50 heavily pretreated lymphoma patients.
    Clinical and laboratory haematology, 1999, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Blood Platelets; Cisplatin; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lymphoma; Middle Aged; Myeloablative Agonists; Time Factors; Transplantation, Autologous

1999
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Podophyllotoxin; Survival Rate; Transplantation Conditioning; Transplantation, Homologous

1999
Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Lymphoma; Male; Mice; Mice, Inbred C3H; Proto-Oncogene Proteins c-bcl-2

1999
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
    British journal of haematology, 2000, Volume: 108, Issue:4

    Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous

2000
Primary central nervous system lymphoma: a clinicopathological study of 28 cases.
    Hematological oncology, 2000, Volume: 18, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Spinal Cord Neoplasms; Survival Analysis; Time Factors

2000
Automated immature reticulocyte counts are early markers of engraftment following autologous PBSC transplantation in patients with lymphoma.
    Journal of hematotherapy & stem cell research, 2000, Volume: 9, Issue:2

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Automation; Biomarkers; Carmustine; Cytarabine; Female; Flow Cytometry; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Neutrophils; Podophyllotoxin; Predictive Value of Tests; Reticulocyte Count; Reticulocytes; Time Factors; Transplantation, Autologous

2000
Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.
    Cancer, 2001, Jan-01, Volume: 91, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Humans; Infusions, Intravenous; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy; Retrospective Studies; Survival Analysis; Treatment Outcome

2001
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
    American journal of clinical pathology, 2001, Volume: 115, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine

2001
Primary isolated lymphoma of the fourth ventricle: case report.
    Journal of neuro-oncology, 2001, Volume: 51, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Ventricles; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Magnetic Resonance Imaging; Methotrexate

2001
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.
    Journal of neurology, neurosurgery, and psychiatry, 2001, Volume: 71, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Humans; Injections, Intraventricular; Lymphoma; Male; Methotrexate; Middle Aged; Pilot Projects; Survival Analysis; Treatment Outcome

2001
Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma.
    Leukemia & lymphoma, 2001, Volume: 40, Issue:5-6

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Hydroxyurea; Leukemia, Myeloid; Lymphoma; Neoplasms, Multiple Primary; Remission Induction; Vidarabine

2001
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation

2002
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
    British journal of haematology, 2002, Volume: 116, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Purging; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Half-Life; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Metabolic Clearance Rate; Middle Aged; Polymerase Chain Reaction; Prednisone; Recurrence; Rituximab; Transplantation, Autologous; Vincristine

2002
Green urine in a critically ill patient.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 39, Issue:4

    Topics: Adult; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma; Male; Neutropenia; Sepsis; Urine

2002
Reversible changes in duodenal mucosa associated with intensive chemotherapy followed by autologous marrow rescue.
    Lancet (London, England), 1979, Sep-08, Volume: 2, Issue:8141

    Topics: Antineoplastic Agents; Bone Marrow Transplantation; Child, Preschool; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Duodenum; Humans; Ileal Neoplasms; Intestinal Mucosa; Lymphoma; Male; Transplantation, Autologous; Vincristine

1979
Meningeal involvement in leukemias and malignant lymphomas of adults: incidence, course of disease, and treatment for prevention.
    Acta neurologica Scandinavica, 1979, Volume: 60, Issue:6

    Topics: Adult; Cytarabine; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Meningeal Neoplasms; Methotrexate; Prognosis; Retrospective Studies; Time Factors

1979
Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice.
    Journal of the National Cancer Institute, 1978, Volume: 60, Issue:5

    Topics: Animals; Antigens, Neoplasm; Cytarabine; Dacarbazine; Female; Graft Rejection; H-2 Antigens; Immunity; Lymphoma; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Homologous; Triazenes

1978
Two dimensional view of combination chemotherapy in vitro.
    American journal of hematology, 1978, Volume: 4, Issue:1

    Topics: Cell Line; Cell Survival; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Lymphocytes; Lymphoma; Methotrexate; Prednisolone; Vincristine

1978
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    Cancer, 1976, Volume: 38, Issue:4

    Topics: Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine

1976
[Therapeutical evaluation of two chemotherapy regimens in 38 non-Hodgkin lymphomas (author's transl)].
    Sangre, 1977, Volume: 22, Issue:5B

    Topics: Antineoplastic Agents; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Lymphoma; Male; Prednisone; Vincristine

1977
Drugs five years later: cytarabine.
    Annals of internal medicine, 1975, Volume: 82, Issue:5

    Topics: Acute Disease; Adult; Animals; Bone Marrow Diseases; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Prednisone; Remission, Spontaneous; Thioguanine; Vincristine; Virus Diseases

1975
Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
    The British journal of cancer. Supplement, 1975, Volume: 2

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Skin Neoplasms; Stomach Neoplasms; Thioguanine; Vincristine

1975
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Cancer, 1975, Volume: 36, Issue:6

    Topics: Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine

1975
Non-Hodgkin's lymphoma in children.
    Medical and pediatric oncology, 1975, Volume: 1, Issue:3

    Topics: Adolescent; Asparaginase; Bone Marrow; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Hydroxyurea; Lymphoma; Male; Methotrexate; Neoplasm Metastasis; Nitrogen Mustard Compounds; Peripheral Nervous System Neoplasms; Prednisone; Prognosis; Thioguanine; Vincristine

1975
Letter: Intravenous cytarabine in treatment of herpes zoster in haematological malignancy.
    British medical journal, 1976, Jan-24, Volume: 1, Issue:6003

    Topics: Adolescent; Adult; Aged; Child; Cytarabine; Female; Herpes Zoster; Humans; Leukemia; Lymphoma; Male; Middle Aged

1976
Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy.
    Cancer, 1976, Volume: 37, Issue:1

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Lymphoma; Male; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Prednisone; Thioguanine; Vinblastine; Vincristine

1976
Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.
    Bone marrow transplantation, 1992, Volume: 10, Issue:4

    Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Blood Component Removal; Blood Transfusion, Autologous; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Male; Middle Aged; Recombinant Proteins

1992
Neuropsychologic impairment in adult bone marrow transplant candidates.
    Cancer, 1992, Nov-01, Volume: 70, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Attention; Bone Marrow Transplantation; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cognition Disorders; Cranial Irradiation; Cytarabine; Female; Humans; Leukemia; Lymphoma; Male; Memory; Methotrexate; Middle Aged; Neuropsychology; Psychomotor Performance; Regression Analysis; Whole-Body Irradiation

1992
Polyneuritis after HD Ara-C therapy for malignant lymphoma.
    Italian journal of neurological sciences, 1992, Volume: 13, Issue:1

    Topics: Adult; Cytarabine; Female; Humans; Lymphoma; Polyneuropathies

1992
Effect of the dosing interval on myelotoxicity and survival in mice treated by cytarabine.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:6-7

    Topics: Animals; Bone Marrow; Cell Cycle; Cytarabine; Drug Administration Schedule; Lymphoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Tumor Cells, Cultured

1992
Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.
    Chest, 1990, Volume: 98, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Humans; Lung; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Pneumothorax; Prednisone; Procarbazine; Radiography; Vinblastine; Vincristine

1990
Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside.
    Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:3

    Topics: Arabinofuranosyluracil; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Half-Life; Humans; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged

1992
Experience with salvage regimens at M.D. Anderson Hospital.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoguazone; Mitoxantrone; Remission Induction; Survival Rate

1991
Role of levamisole as immunomodulant in mouse lymphoma model.
    Immunopharmacology and immunotoxicology, 1991, Volume: 13, Issue:3

    Topics: Animals; Carmustine; Cytarabine; Dacarbazine; Drug Synergism; Female; Immune Tolerance; Levamisole; Lymphoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Transplantation, Homologous

1991
Lymphomatous polyneuropathy. Biopsy of clinically involved nerve and successful treatment.
    Archives of neurology, 1991, Volume: 48, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cytarabine; Electrophysiology; Female; Humans; Leg; Leucovorin; Lymphoma; Methotrexate; Nervous System; Nervous System Neoplasms; Vincristine

1991
Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
    Bone marrow transplantation, 1990, Volume: 6, Issue:6

    Topics: Bone Marrow Transplantation; Cerebellar Diseases; Cyclosporins; Cytarabine; Diarrhea; Evaluation Studies as Topic; Female; Georgia; Humans; Leukemia; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Preoperative Care; Remission Induction; Retinitis; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation

1990
Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.
    Cancer research, 1990, Feb-01, Volume: 50, Issue:3

    Topics: Basement Membrane; Breast Neoplasms; Cytarabine; Humans; In Vitro Techniques; Lymphoma; Magnetic Resonance Spectroscopy; Nucleotidyltransferases; Phosphatidylcholines; Phosphatidylethanolamines; Phosphoric Diester Hydrolases; Tumor Cells, Cultured

1990
[Management results of primary intracranial malignant lymphoma].
    No shinkei geka. Neurological surgery, 1990, Volume: 18, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; Cytarabine; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lymphoma; Male; Methotrexate; Middle Aged; Nimustine; Prognosis; Radiotherapy Dosage

1990
Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma.
    Bone marrow transplantation, 1990, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cytarabine; Dexamethasone; Drug Therapy, Combination; Female; Hematopoiesis; Hematopoietic Stem Cells; Humans; Lymphoma; Male; Middle Aged; Transplantation, Autologous

1990
BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma.
    Blood, 1990, Jun-15, Volume: 75, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Humans; Lymphoma; Middle Aged; Survival Analysis; Time Factors

1990
Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphoma.
    Cancer investigation, 1990, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Lymphoma; Male; Middle Aged; Mitoguazone; Pilot Projects

1990
Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy.
    Biochimica et biophysica acta, 1990, Jul-09, Volume: 1026, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cross-Linking Reagents; Cytarabine; Drug Carriers; Flow Cytometry; Immunotoxins; Liposomes; Lymphoma; Maleimides; Mice; Microscopy, Electron; Microscopy, Electron, Scanning; Prodrugs; Rats; Succinimides; Sulfides; T-Lymphocytes; Tumor Cells, Cultured

1990
High-dose cytosine arabinoside-associated pancreatitis.
    Cancer, 1985, Oct-15, Volume: 56, Issue:8

    Topics: Adult; Amylases; Cytarabine; Female; Humans; Isoenzymes; Leukemia; Lipase; Lymphoma; Nausea; Pain; Pancreatitis; Retrospective Studies

1985
Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Teniposide; Vincristine

1986
Treatment of intraocular lymphoma with high-dose Ara-C.
    Cancer, 1986, Apr-01, Volume: 57, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Eye Neoplasms; Female; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Palliative Care

1986
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives.
    International journal of cancer, 1987, Jun-15, Volume: 39, Issue:6

    Topics: Animals; Azacitidine; Carmustine; Cell Line; Cytarabine; Dacarbazine; DNA, Neoplasm; Lymphoma; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Quinacrine; Triazenes

1987
AIDS-related malignant lymphoma: results of prospective treatment trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Vincristine

1987
Acute myeloid leukaemia presenting with pleural effusions.
    Clinical and laboratory haematology, 1989, Volume: 11, Issue:4

    Topics: Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Histocompatibility Antigens; Humans; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Lymph Nodes; Lymphoma; Male; Middle Aged; Mitoxantrone; Pleural Effusion; Remission Induction

1989
The role of peripheral blood stem cells as rescue after myeloablative therapy.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 1

    Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Combined Modality Therapy; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Transplantation, Autologous

1989
Use of anti-idiotypic antibody-drug conjugates to treat experimental murine B-cell tumors.
    Methods in enzymology, 1989, Volume: 178

    Topics: Animals; Antibodies, Anti-Idiotypic; Antineoplastic Agents; B-Lymphocytes; Cisplatin; Cytarabine; Daunorubicin; Doxorubicin; Immunoglobulin M; Lymphoma; Mice; Tumor Cells, Cultured

1989
Central nervous system involvement in haematological malignancies.
    Clinical and laboratory haematology, 1989, Volume: 11, Issue:4

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Humans; Injections, Spinal; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Remission Induction; Spinal Neoplasms

1989
Results of treatment in children with B-cell lymphoma: report on the Polish Leukemia/Lymphoma Study Group.
    Haematology and blood transfusion, 1989, Volume: 32

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Infant; Lymphoma; Methotrexate; Retrospective Studies; Vincristine

1989
Chemotherapy in the management of intraocular lymphoma.
    Cancer, 1989, May-15, Volume: 63, Issue:10

    Topics: Adult; Aged; Combined Modality Therapy; Cytarabine; Drug Evaluation; Eye Neoplasms; Female; Humans; Infusions, Intravenous; Lymphoma; Male; Middle Aged

1989
Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors. II. Ara-C does not inhibit the later process in lymphoid cells.
    Biochemical and biophysical research communications, 1989, Sep-15, Volume: 163, Issue:2

    Topics: AraC Transcription Factor; Bacterial Proteins; Choline; Cytarabine; Deoxycytidine; DNA; Humans; Infant; Lymphoid Tissue; Lymphoma; Phospholipids; Repressor Proteins; Thymidine; Transcription Factors; Tumor Cells, Cultured

1989
Immunospecific targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumor in vitro and in vivo.
    Cancer research, 1989, Jan-15, Volume: 49, Issue:2

    Topics: Animals; Antigen-Antibody Reactions; B-Lymphocytes; Bromodeoxyuridine; Cytarabine; Female; Immunoglobulin Idiotypes; Liposomes; Lymphoma; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Surface Properties

1989
Pharmacology studies of 1-beta-D-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug.
    Cancer research, 1989, Jan-01, Volume: 49, Issue:1

    Topics: Adolescent; Child; Child, Preschool; Cytarabine; Deoxycytidine Kinase; Humans; Infant; Leukemia; Lymphoma

1989
Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosi
    Cancer treatment reports, 1986, Volume: 70, Issue:8

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neutropenia; Peripheral Nervous System Diseases; Prednisone; Prognosis; Thrombocytopenia; Vincristine

1986
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
    Seminars in hematology, 1988, Volume: 25, Issue:2 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Methylprednisolone; Mitoguazone; Transplantation, Autologous

1988
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematologic Diseases; Humans; Leukemia, Lymphoid; Lymphoma; Male; Melphalan; Middle Aged; Recurrence; Remission Induction; Thymoma; Thymus Neoplasms

1988
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma.
    Journal of the National Cancer Institute, 1988, Nov-02, Volume: 80, Issue:17

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain; Brain Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Lymphoma; Male; Middle Aged

1988
[BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:10

    Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Female; Humans; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Male; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction

1988
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Podophyllotoxin

1988
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
    Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1

    Topics: Adolescent; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cytarabine; Humans; Leukemia; Lymphoma; Whole-Body Irradiation

1987
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).
    Blood, 1988, Volume: 71, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Cytarabine; Dexamethasone; Drug Evaluation; Humans; Lymphoma; Middle Aged; Multiple Organ Failure; Nervous System Diseases

1988
Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:8

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia, Lymphoid; Lymphoma; Male; Meningeal Neoplasms; Methotrexate; Middle Aged

1986
Staging and therapy of orbital lymphomas.
    Cancer, 1986, Mar-15, Volume: 57, Issue:6

    Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Prednisone; Prognosis; Radionuclide Imaging; Vincristine

1986
Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen.
    Cancer treatment reports, 1986, Volume: 70, Issue:6

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Vincristine

1986
Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma.
    Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Female; Hodgkin Disease; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin

1986
Cerebellar toxicity with high-dose cytosine arabinoside.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Cerebellar Diseases; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Leukemia; Lymphoma; Male; Middle Aged

1987
CYTOSAR-U sterile powder: therapeutic biological effects. Proceedings of a symposium. November 30-December 2, 1986, Kalamazoo, MI.
    Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1

    Topics: Acute Disease; Animals; Cytarabine; Humans; Leukemia; Lymphoma

1987
Phase I clinical and pharmacokinetic study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Medical oncology and tumor pharmacotherapy, 1986, Volume: 3, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; Female; Hematopoiesis; Humans; Kinetics; Leukemia; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged

1986
Antimetabolites in combination with other drugs improve therapy of diffuse aggressive non-Hodgkin's lymphoma.
    Cancer investigation, 1986, Volume: 4, Issue:2

    Topics: Actuarial Analysis; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Humans; Lymphoma; Methotrexate; Pilot Projects; Risk

1986
[High dose cytosine arabinoside (HDCA) in children with refractory leukemia or malignant lymphoma (3 g/m2 vs 1.5 g/m2)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1985, Volume: 26, Issue:12

    Topics: Adolescent; Child; Cytarabine; Female; Humans; Kinetics; Leukemia; Lymphoma; Male

1985
A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine.
    Blood, 1985, Volume: 66, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Cytarabine; Drug Therapy, Combination; Female; Humans; Infant; Injections, Spinal; Lymphoma; Male; Methotrexate; Podophyllotoxin; Prognosis; Teniposide; Thymus Gland

1985
High-dose cytosine arabinoside in the treatment of childhood malignancies.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Diterpenes; Doxorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Pancytopenia; Recurrence; Retinyl Esters; Vitamin A; Vomiting

1985
[Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:11

    Topics: Adult; Asparaginase; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged

1985
[High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1985, Volume: 26, Issue:8

    Topics: Adolescent; Adult; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia; Leukemia, Myeloid; Lymphoma; Male; Middle Aged

1985
Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Acute Disease; Adolescent; Adult; B-Lymphocytes; Bacterial Infections; Burkitt Lymphoma; Cerebellar Ataxia; Child; Child, Preschool; Cytarabine; Female; Gastrointestinal Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Neutropenia; Recurrence; Thrombocytopenia

1985
High-dose adriamycin combination chemotherapy for intermediate and high-grade non-Hodgkin's lymphomas.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Prednisone; T-Lymphocytes; Thrombocytopenia; Vincristine

1985
Production of colony stimulating factor by EL-4 lymphoma cells stimulated with phytohemoagglutinin.
    International journal of immunopharmacology, 1985, Volume: 7, Issue:4

    Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cell Line; Colony-Forming Units Assay; Colony-Stimulating Factors; Cytarabine; Female; Kinetics; Lymphocyte Activation; Lymphoma; Mice; Mice, Inbred BALB C; Phytohemagglutinins; T-Lymphocytes

1985
Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:12

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Vincristine

1985
[Principles of high-dose cytarabinoside treatment].
    Onkologie, 1985, Volume: 8, Issue:1

    Topics: Acute Disease; Bone Marrow; Cell Cycle; Cytarabine; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Metabolic Clearance Rate; RNA, Neoplasm

1985
[Results of high-dose cytarabine therapy. A review].
    Onkologie, 1985, Volume: 8, Issue:1

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma

1985
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Central Nervous System Diseases; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Diarrhea; Graft vs Host Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Pulmonary Fibrosis; Skin Diseases; Whole-Body Irradiation

1985
Central nervous system toxicity with high-dose cytosine arabinoside.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Acute Disease; Aging; Central Nervous System Diseases; Combined Modality Therapy; Cytarabine; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Middle Aged; Whole-Body Irradiation

1985
Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
    Cancer treatment reports, 1985, Volume: 69, Issue:9

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytotoxicity, Immunologic; Drug Evaluation; Female; Hematopoietic Stem Cells; Humans; Leukemia, Lymphoid; Lymphoma; Male; Mediastinal Neoplasms; Prognosis; Ricin; Specimen Handling; Whole-Body Irradiation

1985
Synergistic effect of radiation and N-nitrosoethylurea in the induction of lymphoma in mice: cellular kinetics and carcinogenesis.
    Japanese journal of cancer research : Gann, 1985, Volume: 76, Issue:1

    Topics: Animals; Bone Marrow; Cocarcinogenesis; Cytarabine; DNA; Ethylnitrosourea; Female; Lymphoma; Methylation; Mice; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Nitrosourea Compounds; Thymus Gland

1985
[Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1

    Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia; Lymphoma; Male; Myeloproliferative Disorders; Podophyllotoxin

1986
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1

    Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine

1986
Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma.
    Archives of internal medicine, 1986, Volume: 146, Issue:4

    Topics: Brain Neoplasms; Corpus Callosum; Cytarabine; Female; Frontal Lobe; Humans; Infusions, Parenteral; Lymphoma; Middle Aged; Spinal Neoplasms

1986
Analysis of the drug synergism between thymidine and arabinosyl cytosine using mouse S49 T lymphoma mutants.
    Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:1

    Topics: Animals; Cells, Cultured; Cytarabine; Deoxycytosine Nucleotides; Drug Synergism; Lymphoma; Mice; Mutation; Thymidine; Thymine Nucleotides

1985
Treatment of diffuse aggressive non-Hodgkin's lymphomas with an intensive multi-drug regimen including high-dose cytosine arabinoside (F-MACHOP).
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Vincristine

1985
The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Cytarabine; Doxorubicin; Humans; Lymphoma; Middle Aged; Neutropenia; Prednisolone; Recurrence; Skin Diseases; Thrombocytopenia; Vincristine

1985
High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphoma.
    Cancer, 1985, Oct-01, Volume: 56, Issue:7

    Topics: Adolescent; Adult; Aged; Cytarabine; Female; Humans; Lymphoma; Male; Middle Aged; Prognosis

1985
Cytarabine-cis-platin interactions in patients with advanced cancer.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Bronchogenic; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Kidney Diseases; Leukopenia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia

1985
A two-stage therapeutic design in the spontaneous AKR lymphoma system.
    Cancer research, 1972, Volume: 32, Issue:6

    Topics: Amides; Animals; Antineoplastic Agents; Azacitidine; Cyclic P-Oxides; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Female; Imidazoles; Lymphoma; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred Strains; Oxazines; Prednisone; Remission, Spontaneous; Time Factors; Triazenes; Vincristine

1972
Cytosine arabinoside in herpes zoster.
    Lancet (London, England), 1973, Jan-06, Volume: 1, Issue:7793

    Topics: Adult; Aged; Cytarabine; Female; Herpes Zoster; Humans; Lymphoma; Male; Middle Aged

1973
Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys.
    International journal of cancer, 1973, Jul-15, Volume: 12, Issue:1

    Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Viral; Antibody Formation; Antigen-Antibody Complex; Antigen-Antibody Reactions; Antigens, Viral; Cells, Cultured; Culture Media; Cytarabine; Fluorescent Antibody Technique; Haplorhini; Herpesviridae; Immune Sera; Immunoglobulin E; Leukocyte Count; Lymphocytes; Lymphoma; Neoplasm Transplantation; Neoplasms, Experimental; Oncogenic Viruses; Staining and Labeling; Time Factors; Transplantation, Homologous

1973
Metabolic inhibitors and viral lymphomagenesis in thymic grafts.
    Journal of the National Cancer Institute, 1974, Volume: 53, Issue:2

    Topics: Animals; Antimetabolites; Cytarabine; Dactinomycin; Female; Immunity; Leukemia Virus, Murine; Lymphoma; Male; Mice; Puromycin; Regeneration; Rifampin; Streptonigrin; Streptovaricin; Thymectomy; Thymus Gland

1974
Chemotherapy of Herpesvirus saimiri induced lymphoma-leukemia in the owl monkey.
    Journal of medical primatology, 1974, Volume: 3, Issue:1

    Topics: Adenine; Animals; Arabinose; Cyclophosphamide; Cytarabine; Disease Models, Animal; Haplorhini; Herpesviridae; Hydrocortisone; Interferons; Leukemia, Lymphoid; Leukocyte Count; Lymphoma; Monkey Diseases; Oncogenic Viruses; Vincristine; Virus Replication

1974
Polynucleotide ligase activity in cells infected with simian virus 40, polyoma virus, or vaccinia virus.
    Journal of virology, 1969, Volume: 4, Issue:5

    Topics: Animals; Carbon Isotopes; Cell Line; Cell Nucleus; Chick Embryo; Cricetinae; Cytarabine; Cytoplasm; DNA Replication; DNA, Viral; Embryo, Mammalian; Fibroblasts; Haplorhini; HeLa Cells; Humans; Kidney; Ligases; Lymphoma; Mice; Neoplasms, Experimental; Polyomavirus; Puromycin; Rifampin; Simian virus 40; Thymoma; Vaccinia virus

1969
Spontaneous AK leukemia (lymphoma) as a model for human leukemias and lymphomas.
    Cancer chemotherapy reports. Part 3, 1972, Volume: 3, Issue:1

    Topics: Animals; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Leukemia Virus, Murine; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred Strains; Remission, Spontaneous; Thymectomy; Time Factors; Vincristine

1972
The repair of methyl methanesulphonate-induced lesions in the DNA of a murine lymphoma cell.
    Chemico-biological interactions, 1973, Volume: 7, Issue:6

    Topics: Animals; Cell Line; Centrifugation, Density Gradient; Cytarabine; Deoxycytidine; DNA Repair; DNA Replication; DNA, Single-Stranded; Hydroxyurea; Lymphocytes; Lymphoma; Mesylates; Mice; Mice, Inbred Strains; Radiation Effects; Spectrophotometry, Ultraviolet; Tritium

1973
The combined effect of drugs and tumor-specific antibodies in protection against a mouse lymphoma.
    Cancer research, 1974, Volume: 34, Issue:11

    Topics: Animals; Antibodies, Neoplasm; Chlorambucil; Cytarabine; Immune Sera; Immunotherapy; Lymphoma; Melphalan; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Rabbits; Time Factors

1974
Enhancement of the cancer chemotherapeutic effect of the cell cycle phase specific agents methotrexate and cytosine arabinoside when given as a water-oil-water emulsion.
    European journal of cancer, 1974, Volume: 10, Issue:1

    Topics: Animals; Carcinoma 256, Walker; Cytarabine; Emulsions; Lymphoma; Methotrexate; Mice; Neoplasms, Experimental; Squalene; Time Factors; Water

1974
Combination chemotherapy for spontaneous AKR lymphoma.
    Cancer chemotherapy reports. Part 2, 1974, Volume: 4, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Lymphoma; Methotrexate; Mice; Mice, Inbred AKR; Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Palmitic Acids; Prednisone; Remission, Spontaneous; Rodent Diseases; Spleen; Splenomegaly; Thymus Gland; Time Factors; Vincristine

1974
In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.
    Biochemical pharmacology, 1972, Volume: 21, Issue:1

    Topics: Aminohydrolases; Carbon Isotopes; Cytarabine; Deamination; Female; Humans; Kinetics; Leukemia, Myeloid; Lymphoma; Male; Mathematics; Models, Biological; Uracil

1972
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Cancer research, 1974, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Hodgkin Disease; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred AKR; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Vinblastine; Vincristine

1974
Mediastinal adenopathy in granulocytic leukemia.
    Archives of internal medicine, 1974, Volume: 134, Issue:1

    Topics: Adult; Busulfan; Cytarabine; Diagnosis, Differential; Female; Humans; Leukemia, Myeloid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Thioguanine

1974
Alterations of granulopoiesis following chemotherapy.
    Blood, 1974, Volume: 44, Issue:3

    Topics: Adult; Aged; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Cell Division; Clone Cells; Cytarabine; DNA; Doxorubicin; Female; Glycoproteins; Hematopoiesis; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Mitosis; Muramidase; Thioguanine; Thymidine; Tritium

1974
Blood and neoplastic diseases. Rational approach to the chemotherapy of human malignant disease-II.
    British medical journal, 1974, Oct-26, Volume: 4, Issue:5938

    Topics: Antineoplastic Agents; Brain Neoplasms; Busulfan; Cell Count; Cell Division; Cytarabine; Diffusion; Drug Tolerance; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Lymphoma; Methotrexate; Multiple Myeloma; Neoplasms; Vincristine

1974
The effects of arabinosylcytosine on cultured human lymphoma cells.
    Cancer research, 1972, Volume: 32, Issue:12

    Topics: Aminohydrolases; Cell Line; Cell Survival; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; Humans; Lymphoma; Phosphotransferases; Thymidine; Time Factors; Tritium

1972
Effects of inhibitors of protein and nucleic acid synthesis on the expression of H-2 and Moloney leukemia virus-determined cell-surface antigens on cultured murine lymphoma cells.
    Journal of the National Cancer Institute, 1972, Volume: 48, Issue:2

    Topics: Animals; Antigens; Antigens, Neoplasm; Antigens, Viral; Antineoplastic Agents; Cell Membrane; Cells, Cultured; Culture Media; Cycloheximide; Cytarabine; Dactinomycin; Histocompatibility Antigens; Hydroxyurea; Lymphoma; Mice; Mitomycins; Moloney murine leukemia virus; Neoplasm Proteins; Neoplasms, Experimental; Puromycin; RNA, Neoplasm

1972
Action of 1- -D-arabinofuranosylcytosine on mammalian tumor cells. 1. Incorporation into DNA.
    European journal of cancer, 1972, Volume: 8, Issue:4

    Topics: Animals; Cells, Cultured; Centrifugation, Density Gradient; Chromatography, Thin Layer; Cytarabine; DNA, Neoplasm; Lymphoma; Mice; Tritium

1972
Chemotherapy of malignant lymphoma with adriamycin.
    Cancer research, 1973, Volume: 33, Issue:11

    Topics: Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Hematopoietic System; Hodgkin Disease; Humans; Injections, Intravenous; Leukemia; Lymphoma; Prednisone; Remission, Spontaneous; Vincristine

1973
The clinical uses of cytosine arabinoside in retinoblastoma and lymphoma.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1973, Volume: 56, Issue:9

    Topics: Adult; Aged; Child; Child, Preschool; Cytarabine; Eye Neoplasms; Female; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Remission, Spontaneous; Retinoblastoma

1973
Combination chemotherapy: the antagonism of methotrexate and cytosine arabinoside.
    European journal of cancer, 1973, Volume: 9, Issue:3

    Topics: Animals; Cell Line; Cytarabine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Lymphoma; Methotrexate; Mice

1973
Multiple emulsions, a suitable vehicle to provide sustained release of cancer chemotherapeutic agents.
    British journal of pharmacology, 1972, Volume: 45, Issue:1

    Topics: Animals; Antineoplastic Agents; Cytarabine; Delayed-Action Preparations; Diarrhea; Emulsions; Lymphoma; Methotrexate; Mice; Neoplasms, Experimental; Pharmaceutical Vehicles; Rats; Vinblastine; Vomiting

1972
Action of 1- -D-arabinofuranosylcytosine on mammalian tumor cells. 2. Inhibition of mammalian and oncogenic viral polymerases.
    European journal of cancer, 1972, Volume: 8, Issue:4

    Topics: Animals; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; DNA Nucleotidyltransferases; Leukemia; Liver; Lymphoma; Mice; Oncogenic Viruses; Rauscher Virus

1972
Leukemia and lymphoma.
    Geriatrics, 1970, Volume: 25, Issue:12

    Topics: Antineoplastic Agents; BCG Vaccine; Burkitt Lymphoma; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Prednisone; Vincristine

1970
Cytarabine.
    The Medical letter on drugs and therapeutics, 1971, Jan-08, Volume: 13, Issue:1

    Topics: Acute Disease; Amino Sugars; Anemia; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Cyclophosphamide; Cytarabine; Glycosides; Humans; Injections, Intravenous; Injections, Subcutaneous; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukopenia; Lymphoma; Prednisone; Remission, Spontaneous; Thioguanine; Thrombocytopenia; Vincristine

1971
Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia.
    Cancer chemotherapy reports, 1969, Volume: 53, Issue:6

    Topics: Age Factors; Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Leukemia L1210; Leukemia, Experimental; Lymphoma; Mice; Time Factors; Vincristine

1969
Reduction of colony-forming cell sensitivity to arabinosylcytosine by halothane anesthesia.
    Cancer research, 1970, Volume: 30, Issue:6

    Topics: Anesthesia, Inhalation; Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Cytarabine; Drug Synergism; Female; Halothane; Lymphoma; Mice; Neoplasms, Experimental; Nitrous Oxide; Splenic Neoplasms; Vinblastine

1970
Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.
    Journal of the National Cancer Institute, 1969, Volume: 42, Issue:6

    Topics: Animals; Cell Line; Cytarabine; Female; Hematopoiesis; Lymphoma; Male; Methotrexate; Mice; Radiation Effects; Time Factors; Vinblastine; Vincristine

1969
Cytosine arabinoside (NSC-63878) given subcutaneously to patients with cancer.
    Cancer chemotherapy reports, 1969, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Aged; Blood Cell Count; Child; Cytarabine; Female; Humans; Injections, Subcutaneous; Leukemia; Lymphoma; Male; Middle Aged

1969